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Polymer-based microelectrophoresis was investigated to analyze known 
(mutation detection) and unknown (mutation scanning) low-abundant mutations in 
genomic DNA with high diagnostic value for colorectal cancers.  For our mutation 
detection assays, point mutations in the K-ras oncogene were identified using the ligase 
detection reaction (LDR). For the mutation scanning assay, which searches for sporadic 
mutations, an EndoV-LDR assay was utilized with mutations in the p53 tumor 
suppressor gene used as a model.    
A poly(methylmethacrylate), PMMA, microchip filled with a 4% linear 
polyacrylamide (LPA) gel was used to electrophoretically sort products formed from 
LDRs, which produced oligonucleotides <65 bp in length. Using microchip 
electrophoresis with the LPA, a 44 bp ligation product was resolved from a 100-fold 
molar excess of unligated primers (25 bp) in approximately 120 s, which was ~17 times 
faster than conventional capillary gel electrophoresis.   
In order to simplify the electrophoretic process and further reduce development 
time, the LDR products were sorted in the absence of the sieving gel using free solution 
conjugate electrophoresis (FSCE).  FSCE incorporated polyamide “drag-tags” onto LDR 
primers, which provided DNA fragment mobilities in free solution that were dependent 
upon their size.  LDR/drag-tagged (LDR-dt) products could be formed in a multiplexed 
format for mutant-to-wild-type ratios as low as 1 to 100 with single base resolution.  
Separations were conducted using capillary array electrophoresis (CAE) and PMMA 
microchips filled with only a TRIS buffer.  Analysis times for the LDR-dt products were 
less than 11 min using CAE and ~85 s for PMMA microchips with high reproducible 
migration times within and between microchips.  
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PMMA-based microchips were also evaluated for the identification of sporadic 
mutations using an endonuclease V – LDR (Endo V/LDR) technique. Endo V cleaves 
heteroduplexed DNA one base 3’ of single-base mismatched sites as well as nicking 
DNA at some matched sites as LDR reseals miscleaved sites to reduce false positive 
signals. Results suggested that Endo V/LDR products from p53 mutations could be 
successfully separated and detected using a PMMA microfluidic chip filled with a 
sparsely cross-linked replaceable polyacrylamide gel in less than 6 min, which was 










Chapter 1:  Advances in Genotyping 
1.1 Overview of DNA 
All of the tremendously diverse biological attributes of life are governed by the 
mere sequence of a simple, four-alphabet genetic code – that of deoxyribonucleic acid 
(DNA).  Housed in the nuclei of cells in dense bundles known as chromosomes, DNA is 
a biopolymer containing the genetic instructions that transcribe ribonucleic acid (RNA) 
molecules, which are in turn translated into functional, regulatory enzymes or highly 
organized structural components ascending from proteins to organelles to cells.  DNA 
exists in long strands comprised of four unique nucleosides:  adenine (A), cytosine (C), 
guanine (G) and thymine (T) (see Figure 1.1).  Each strand is held together by a sugar-
phosphate backbone, which gives the macromolecule a net negative charge.  Together, 
a single sugar-phosphate group and nucleoside comprise DNA monomer units known 
as nucleotides.  Through Watson-Crick pairing, complementary DNA strands conform 
into a double helix via hydrogen bonding between coordinated G/C and A/T bases as 
shown in Figure 1.2.  These weak hydrogen bonds permit two complementary strands 
 





of DNA to easily separate and reestablish pairings under certain physiological 
conditions, such as the process of mitosis whereby two daughter cells are created with 
the exact genetic code as the parent cell.  
 
Figure 1.2.  An annotated diagram depicting the DNA double helix highlighting its 






1.2 Overview of the Human Genome 
In June 2000, some 50 years after the discovery of the DNA double helix, the 
rough draft sequencing of the approximate three billion bases in the human genome 
was completed due to the monumental undertaking of the Human Genome Project 
(HGP).  Upon the initial deciphering of the human genome, we now know that our 
genomes are nearly 99% identical and that they only contain approximately 30,000 – 
40,000 genes instead of the hypothesized 100,000 (one gene per protein), leaving 
about 1% of the human genome that codes for functional components that regulate 
various cellular machinery and processes.  However, this small percentage of the 
human genome accounts for over 90% of all sequence variations that make each 
individual unique [1, 2].   
While this rough draft of the human genome has already aided biomedical 
research, much more sequencing detail is needed.  In fact, it has been predicted that 
medical care will one day be tailored to each individual’s genomic sequence [3].  Aside 
from the discovery of the remaining unidentified genes, the challenge that now remains 
is identifying (genotyping) the subtle differences within various regions of the genome 
known as polymorphisms that are produced from either environmental or inherited 
conditions.  Upon identification, numerous polymorphisms - base substitutions, 
deletions, insertions, or frameshifts (see Figure 1.3) - within an active gene-coding 
region can be used as markers to monitor for the presence of or even susceptibility to 
developing a given disease.  Most polymorphisms are classified as single nucleotide 
polymorphisms (SNP)s wherein a single base is substituted, which can potentially lead 
to genetic mutations and thus, the development of deleterious conditions such as sickle 
cell anemia, muscular dystrophy and many forms of cancer to name just a few. For 
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instance, muscular dystrophy, a highly debilitating and fatal X chromosome-linked 
muscle disorder affecting approximately 1 in 3,500 new-born males, has been traced to 
irregularities in a single gene, dystrophin, measuring 2.4 Mb making it the largest found 
in humans [4].   
 
Figure 1.3.  Depiction of base substitutions, insertions, deletions and frameshifts 
comprising the different types of DNA sequence polymorphisms. 
 
Genetic sequencing information also plays a key role in the development of 
presymptomatic screening assays for the early diagnosis of disease states.  Cancers, 
uncontrolled cell growth initiated by an accumulation of point mutations in functional 
gene regions promoting tumorigenesis, are of particular interest as the relationship 
between time of discovery and survival rates has been well documented in the scientific 
literature [5].   
The onset of colorectal cancer, for example, is highly associated with 19 known 
SNPs within codons 12, 13, and 61 of the K-ras gene, which convert the amino acid 
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glycine to valine in these critical positions, making the gene oncogenic.  The ras gene is 
a signal transduction protein producer (GTPase), which under normal functionality is 
activated by guanine exchange factors and inactivated by GTPase-activating proteins 
via GTP hydrolysis of ras back to its GDP form.  However, the K-ras oncogene 
continually encodes 21 Kb hydrolysis-resistant GTPase analogs (cell growth signals), 
thus stimulating growth and differentiation of cells autonomously [6, 7].  On the other 
hand, tumor suppressor genes, such as the p53 gene, are also highly associated with 
the onset of colorectal cancer.  The p53 tumor suppressor protein is a multi-functional 
transcription factor that regulates cellular processes affecting proliferation and induces 
growth arrest and apoptosis via several pathways [8].  These mutations occur 
sporadically throughout large spans of the gene, mostly in exons 5 – 9 [9].  Therefore, 
both oncogenic and tumor suppressor mutations must be assessed for accurate 
diagnosis of the disease. 
1.3 Genotyping with Fragment Analysis Methods (More information provided in 
Chapter 2) 
 
Equipped with vast insight from the HGP including the locations of genes and 
specific DNA bases within them responsible for the onset of particular disease states, 
small fragments (~100 – 500 bp) encompassing these regions are typically generated 
and probed.  There is an array of fragment analysis genotyping methods including 
single-strand conformational polymorphism (SSCP), heteroduplex analysis (HA), 
minisequencing, short tandem repeats (STR)s, restriction fragment length 
polymorphisms (RFLP)s, and the ligase detection reaction (LDR) to name a few, all of 
which will be discussed in great detail in the following chapter.  Although sequencing is 
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still considered the genotyping gold standard, these methods are often used in lieu of 
sequencing because it is a relatively time-consuming, a laborious process.   
Each fragment analysis method has its advantages and disadvantages with 
respect to simplicity, sensitivity, ease of multiplexing, throughput, and cost.  Therefore, 
the choice of SNP genotyping method varies, depending on the specific needs and 
resources of each laboratory.  Central to most fragment analysis techniques is the 
utilization of the polymerase chain reaction (PCR), which has the ability to exponentially 
amplify a single copy of a gene fragment of interest into millions of synthetic copies as 
shown in Figure 4 [10].  Thereafter, normal and mutagenic DNA fragments are directly 
deciphered by either conformational differences due to sequence composition (i.e., 
SSCP and HA) or size differences elucidated via electrophoretic-based separations 
(i.e., STR).  Other methods require subsequent treatments with enzymes that either 
cleave DNA fragments with endonucleases (e.g., RFLP) or conjoin DNA fragments 
using ligases (e.g., LDR) and are highly dependent on the ability of such enzymes to 
recognize and act only upon DNA bases of interest within a sequence.  Consequently, 
thousands of novel enzymes have been discovered, characterized, and utilized in DNA 
treatments according to their specificity [11]. 
1.4 Genotyping Technology (More information provided in Chapter 2) 
1.4.1 Electrophoresis of DNA 
Gel electrophoresis is the method of choice for sorting DNA fragments.  In 
general, electrophoresis is a method used to separate a heterogeneous population of 
charged particles in a conductive medium under an electric field.  Given DNA is a free-
draining molecule that has a constant size-to-charge ratio that will not permit size-
sorting in free-solution, a porous sieving material must be suspended in the conductive 
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medium in order to induce frictional drag on DNA molecules [12].  Under such 
parameters, an applied electrical field results in the electrophoretic migration of DNAs 
with a frictional force acting in the opposite direction.  The electrical force ( ) is given by 
the equation: 
                                                            (1.1), 
where  is the net charge on the molecule and  is the applied electric field.  The 
frictional force ( ) is described by the equation: 
                                       (1.2), 
where  is the translational friction coefficient and  and  are the distance and time 
 
 





increments, respectively.  Under steady-state conditions where  and  are 
counterbalanced, DNA migrates with a steady-state velocity ( ); 
                       (1.3).                   
Therefore, the movement of DNA molecules can be quantified in terms of its 
electrophoretic mobility ( ) from the equation: 
                                                                (1.4). 
Substituting equation (1.3) into (1.4) yields: 
                                                           (1.5), 
which describes the electrophoretic mobility of a DNA molecule in terms of its charge 
and frictional components.  As mentioned previously, DNA is a net negatively charged 
molecule with a constant size-to-charge ratio.  Since  α ( ), the number of base pairs 
in a DNA chain, and each of these units contribute proportionally to the overall frictional 
drag exerted on the molecule (  α ): 
                                             (1.6).     
Thus, the electrophoretic mobility of a population of DNA molecules in free solution is 
uniform, which explains the necessity of porous sieving materials for their 
electrophoretic separation into well-resolved zones or bands as shown in Figure 1.5.   
1.4.2 DNA Sieving Media 
It was first reported in 1967 that separation profiles utilizing gels occur because smaller 
DNA fragments traverse porous media at greater velocities than larger DNA chains, 
which are subjected to greater friction under an electric field [13].  With gel 
electrophoresis, the extent to which a mixture of DNAs is resolved depends heavily on 
the pore size of a gel medium relative to the DNA size distribution.  For DNA genotyping 
[9] 
 
separations, a host of entangled polymer in solutions of varying concentrations (see 
Table 1.1) or chemically cross-linked networks in solution is commonly utilized.  
Entangled polymers in solution are ideal for automated capillary array 
electrophoresis(CAE) systems because they are easily replaced between runs to 
prevent contamination during successive analyses (see Figure 1.6). 
 
 
Figure 1.5.  An illustration of the use of a porous gel medium to electrophoretically sort 
a mixed DNA population into bands in a slab gel and capillary gel format.  Capillary gel 
format from www.chnola-research.org/.../capilary.htm, 2004.    
 
 Such matrices include poly (ethyleneoxide), PEO, hydroxyethyl cellulose and 
linear polyacrylamide (LPA) to name a few [14].  LPA and its derivatives having ultra-
high molar mass are the most popular sieving material due to their high hydrophilicity 
and excellent DNA separation ability [15].  On the other hand, non-replaceable cross-
linked polyacrylamides in solution are typically used in slab gel formats and have the 
ability to resolve DNA ranging from 6 to 1,000 bp given the appropriate concentration 




Figure 1.6.  Schematic representation of linear and cross-linked polymers in solution. 
 
1.4.3 Dispersion and Band Broadening 
 
The ability to resolve a mixture of solutes into homogeneous zones or bands 
depends on the length of each band, which in turn is dependent on the dispersion 
processes that act on them.  This dispersion leads to band broadening, which causes 
migrating bands to overlap and become indistinct from each other. Such dispersion 
processes include:  longitudinal molecular diffusion, thermal or convective diffusion, 
nonspecific analyte-wall interactions, sample injections and noise presence in the 
detector.  Dispersion can be described as the total variance within the system, , 
which is given by the sum of several contributing factors: 
                                                         (1.7), 
where the subscripts refer to diffusion, temperature gradients, injection, adsorption and 
detection, respectively.  In an ideal system, longitudinal diffusion is the major contributor 
to the total zone variance and all other dispersion factors are negligible.  For 
electrophoretic separations of DNA performed with polymer matrices, longitudinal and 
radial molecular diffusion do not contribute as much to band broadening as in free 
solution separations because the rate at which DNA molecules diffuse in viscous media 
(i.e., ~10-8 – 10-10 cm2/s) [17] is relatively low compared to the rate of diffusion in free 
[11] 
 
Table 1.1. Compilation of experimental conditions with replaceable polymers for high 
performance DNA separations using capillary electrophoresis. Reprinted with 
permission (see Appendix for references within Table) [14]. 
 
. 
solution (i.e., ~10-7 cm2/s)  [18]. As a result, higher efficiencies are achieved with gel 
electrophoresis. 
1.4.3.1 Electroosmotic Flow 
Electroosmotic flow (EOF) is the bulk flow of a solution towards a cathode or 
anode upon voltage application due to the formation of an electric double layer that 
develops at the capillary surface/solution interface.  This phenomenon occurs because 
a plane of shear between the fixed and mobile layers creates a potential difference 
between the layers known as the zeta potential, , which is determined by the charge of 
[12] 
 
a conduit wall.  This phenomenon is dependent upon the surface charge of a conduit as 
well as the pH and the ionic strength of buffered solutions. EOF can be expressed in 
terms of mobility using the equation: 





                                         (1.8), 
where ε is the dielectric constant. The electrophoretic mobility of a solute in the 
presence of the EOF is termed the apparent mobility (µapp), which is expressed as: 
 
eeofapp
  -=                                       (1.9). 
Both electroosmotic and electrophoretic flow within a microchannel have a flat profile as 
shown in Figure 1.7, which is beneficial for band efficiencies.  However, EOF is 
undesirable when performing DNA separations in capillaries because its mobility is 
toward the cathode, opposing the electrophoretic mobility of negatively charged DNA, 
which is toward the anode.  Moreover, highly charged surfaces that lead to EOF also 
result in unwanted analyte-wall interactions.  Thus, surface modifications are 
administered to suppress EOF and analyte-wall interactions.  
 
Figure 1.7.  Plug flow profile and EOF in a capillary tube during electrophoresis adapted 




1.4.3.2 Surface Modification for Suppression of EOF 
To reduce surface charge influences on the separations, the EOF in capillaries 
must be either significantly reduced or eliminated.  This is accomplished by coating 
channel surfaces with polymeric materials. These coatings can either be static through 
means of covalent attachment of the coating materials to the surface, or dynamic, 
whereby a coating is adsorbed onto the wall.  Both methods provide a homogeneous 
surface to reduce dispersion effects, which is especially important as DNA separations 
are dramatically affected by inhomogeneities in surface charges [19].   
One of the earliest reports concerning chemical modifications of capillary 
surfaces is the Hjerten coating method.  This modification involves the coating of 
channel surfaces with a non-cross-linked polyacrylamide to eliminate the EOF in silica 
capillaries through attachment of a thin layer of polyacrylamide groups by reacting the 
SiO- groups with γ methacryloxypropyltrimethoxysilane (γ-MAPS) prior to 
polymerization [20]. 
Dynamic coatings are advantageous because they do not require time-
consuming chemical modifications.  Passivation is typically achieved by either pre-
rinsing the microchannel with a solution containing the adsorptive polymer or additive, 
or by including the coating agents in the run buffer or separation medium.  Dynamic 
coating with self-coating sieving matrices such as poly(dimethylacrylamide) (PDMA) and 
polyvinylpyrrolidone (PVP) are attractive since the coating is regenerated with each 
refilling of the microchannel, which increases the  reproducible of separations over 





1.4.4 Characterization of Electropherograms 
Upon electrophoretic separations, electropherograms reveal bands referred to as 
peaks, whose dispersion can be measured by evaluating the width of the peak at its 
base, . For a Gaussian peak,  
                                                         (1.10), 
where   is the standard deviation of the peak. From this expression, efficiency, , can 
then be expressed as theoretical plates by: 
      (1.11), 
 
where  is the effective length of the capillary (cm). Also, efficiency can be directly 
related to the molecular diffusion by: 
                                                                                        (1.12), 
where  is the diffusion coefficient of the molecule,  is the total length of the capillary 
(cm) and  is time. Substituting 1.12 into 1.11 yields the fundamental electrophoretic 
expression for plate number: 
                                               (1.13). 
Efficiency can also be calculated directly from peak parameters in an 
electropherograms as shown in Figure 1.8 with the following expression: 
                                                 (1.14),   
where tm is the migration time of the peak (see Figure 1.8). The resulting value is then 
normalized to an effective column length of one meter (plates/m).  For gel 
electrophoresis, the major contributor to band broadening for a well-designed system is 
[15] 
 
longitudinal diffusion of the solute molecules. In this instance,  can be directly related 
to the molecular diffusion by: 





=                                                    (1.15).  
Resolution is the degree of separation between the target molecule(s) and other 
molecules within a sample. It is the result of two factors: selectivity (the relative 
difference in the retention of two peaks) and efficiency. Resolution is given by the 
expression:    











R                (1.16), 
the difference in migration times divided by the average width of the two peaks at the 




Figure 1.8. Adjacent peaks in an electropherogram marking migration times and peak 
widths from which efficiency and resolution can be calculated adapted from [23]. 
[16] 
 
                    (1.17), 
where  is the mean mobility of two neighboring components.  
1.5 Evolution of Electrophoretic Genotyping Platforms 
 Driven by the enormous demand for electrophoretic systems with high 
throughput capabilities, automated CAE systems were devised to replace cumbersome 
slab gel systems.  Due to a capillary’s ability to dissipate heat, higher electrical fields 
can be sustained, and thus, faster separations can be performed.  Though these 
commercial instruments remain effective, they are still relatively expensive to operate 
and slow considering the ever expanding post-HGP genotyping demands including 
disease, forensic and ongoing genome sequencing studies [24].  Meanwhile, 
miniaturized microfluidic platforms have gained traction as electrophoretic devices with 
the potential to satisfy these growing genotyping needs [24]. Just as CAE systems 
improved upon slab gel systems for DNA sorting in terms of reduction in sample 
consumption and speed of analysis, microfluidics have improved upon these same 
factors of CAE systems by orders of magnitude (see Table 1.2).  In addition, this  
 
Table 1.2.  Comparison of typical parameters associated with the given electrophoretic 
formats.   
   Slab Gel  Capillary  Microchip  
Analysis Time   2 – 8 h  1 – 2 h  0.5 – 10 min  
Field Strengths  50 – 80 V/cm  100 – 300 V/cm  100 – 300 V/cm  
Sample Load 
Vol.  
1 – 10 μL  1 – 10 nL  10 – 100 pL  
[17] 
 
burgeoning miniaturized (microchip) platform is even more attractive as front-end 
sample processing (e.g., PCR cycling), back-in signal read-out and electrophoretic 
sorting abilities can be combined onto a single wafer creating a micro-total analysis 
system (µTAS), also referred to as a lab-on-a-chip [25]. 
1.5.1 Microfluidic Devices (Detailed microchip genotyping applications provided in 
Chapter 2) 
 
 Microfluidic devices, commonly referred to as microchips, were first used as 
electrophoretic platforms in the early 1990s and they were fabricated with glass and 
silicon substrates because their surface properties and optical clarity were essentially 
identical to capillary tubing [26].  Recently, polymeric (plastic) substrates having 
manageable surface chemistries and adequate clarity have gained favor due to their 
relative low cost and ease of machining, which further enhances the outlook for the 
aforementioned development of µTAS units [27].  Replicates of plastic microchips can 
be mass-produced from a metal mold master containing raised micro-features  
 
 
 Figure 1.9.  (Left) Schematic of a “twin T” microchip typically used for electrophoresis.  




(channels) by injection molding or hot-embossing into an amorphous substrate (see 
Figure 1.9) [28].  
 
Figure 1.10.  Microchip sample loading and corresponding voltage applications through 
a twin T injection zone and the initial separation of the volume-defined sample plug. 
 
Electrophoretic separations carried out on microfluidic devices are similar in 
manner to those performed using a capillary.  The major operational difference lies in 
the sample plug introduction prior to separations.  Capillary injections involve placing a 
tube in a sample vial and electrokinetically pumping sample into it over some given 
period of time, and then returning the capillary to a system buffer vial to perform 
separations.  Alternatively, microchip injections are performed by electrophoretically 
attracting a sample placed in an on-chip reservoir across a separation channel, at which 
point the sample volume within intersecting zone – the sample plug – is simultaneously 
electrophoresed as the residual sample is drawn back into the sample reservoir (see 
Figure 1.10).  Unlike capillary injections, microchip injections do not suffer electrokinetic 
[19] 
 
injection biases whereby smaller charged species are loaded onto a conduit in larger 
quantities than larger, slower moving charged species, thus leading to unrepresentative 
sample loading, particularly for DNA samples [29]. 
1.6 Research Focus 
In the following chapters of this dissertation, the research efforts conducted to 
advance the development of genetic analysis methods on polymer microchips will be 
described.  The focus of this work was the adaptation and transition of DNA mutation 
product separations currently limited to CAE system processing onto inexpensive 
polymer microchips manufactured by our research group. These separation adaptations 
included two novel enzyme-based genotyping methods having high fidelity for correctly 
identifying known and unknown mutations present in low abundances; the ligase 
detection reaction (LDR) and endonuclease V – ligase detection reaction (EndoV/LDR) 
assays, respectively.  The purpose of this work was to set the stage in part for the future 
completion of disposable µTAS units suitable for clinical genetic analyses. 
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Chapter 2:  High Resolution DNA Separations Using Microchip Electrophoresis 




The completion of the Human Genome Project (HGP) approximately 50 years 
after the discovery of the DNA double helix has unveiled a multitude of genetic 
information, which will and has begun to shape future directions in biomedical research 
and others as well.  For instance, we now know that the sequences of human genomes 
are nearly 99% identical and that our genome contains only approximately 30,000 – 
40,000 genes instead of the hypothesized 100,000 (one gene per protein), leaving 
about 1% of the human genome that codes for functional components that regulate 
various cellular machinery and processes.  However, this small percentage of the 
human genome accounts for over 90% of all sequence variations that make each 
individual unique [1, 2].  Aside from the discovery of the remaining unidentified genes, 
the challenge that now remains is identifying (genotyping) the subtle differences within 
various regions of the genome known as polymorphisms that are produced from either 
environmental or inherited conditions and can be linked to a number of diseases.  Most 
polymorphisms are classified as single nucleotide polymorphisms (SNPs) in which a 
single base is substituted, which can potentially lead to genetic mutations and thus, the 
development of deleterious conditions such as sickle cell anemia, muscular dystrophy 
and many forms of cancer to name just a few.   
The undertaking of unraveling the primary structure of our genome (DNA 
sequencing) or looking for unique sequence structural differences within the genome 
(DNA genotyping) has driven the advancement of DNA-based electrophoretic 
technologies significantly beyond the performance metrics that could be realized using 
slab gels, which were the dominate electrophoresis platform used up until the late 
[23] 
 
1990s.  In order to relieve the labor intensive demands associated with slab gels, 
automated high throughput formats of gel electrophoresis were required to meet the 
demands predicated by the HGP.  This was satisfied to a certain extent with the 
development of capillary array electrophoresis (CAE).   
To further reduce the time and overall cost of DNA analysis, planar microfluidic 
devices have been projected as a viable alternative electrophoretic platform.  This has 
lead to the production of a few commercial instruments using glass microchips instead 
of capillaries or slab gels, which have been discussed elsewhere in detail [4].  In Table 
2.1 is provided a basic operational and performance comparison between the 3 
electrophoretic platforms typically used in DNA analysis namely, slab gel, CAE and 
microchip electrophoresis (microchip CE). 
 
Table 2.1. Performance and operational comparison between three different 
electrophoresis platforms used for DNA sequencing. 
a) ABI 377A [73]. 
b) based on ABI 3730xl using standard sequencing conditions [74]. 


















































As seen from the data presented in Table 2.1, CAE and microchip CE offer some 
attractive capabilities, such as the elimination of gel pouring and lane tracking due to the 
boundary conditions imposed on the separations by the walls defining the separation 
channel.  In addition, the small diameter of the separation columns utilized in these 
micro-separation platforms permit the use of higher electric field strengths to 
[24] 
 
significantly reduce electrophoretic development time. As a result of the performance 
capabilities associated with these micro-column separation platforms, they can improve 
throughput compared to slab gel electrophoresis by nearly 3-fold for the CAE format, 
but by nearly an order of magnitude for microchip CE.  The challenge with the micro-
column separation techniques is that they require load volumes that are 3 – 4 orders of 
magnitude smaller than slab gel electrophoresis and as such, place severe demands on 
detection and/or sample pre-processing prior to the separation to build sufficient 
concentrations of the targets for detection.  
In this post-genomic era, DNA separation-based technologies are shifting from 
primarily a research tool into a more diffuse user pool targeting such as clinical 
diagnostics, forensic applications, and small-scale sequencing of individual genomes for 
personalized medicine initiatives.  To realize this transition, DNA-based analysis 
systems must attain certain performance characteristics such as: (1) Development of 
low cost instrumentation that can be easily operated by novice users. Typically, the 
equipment required for processing DNA samples is expensive, difficult to operate and 
maintain and performs only one step of the many steps that are required for DNA 
processing.  For example, many of the CAE-based electrophoretic instruments require 
expensive laser systems for reading fluorescence from the capillary tube(s) in a finish 
line format, gel sieving matrices that are expensive that must be changed after every 
single electrophoretic run and finally, perform only the separation step.  DNA samples 
typically require significant amounts of pre-processing prior to the electrophoresis such 
as purification, amplification via PCR, and labeling of the generated DNA fragments. 
Unfortunately, different instruments are required for each step of the processing 
pipeline, which significantly increases the capitol equipment costs for performing genetic 
[25] 
 
assays as well as demanding high levels of operator expertise. (2) Automation of the 
entire DNA processing pipeline preferably into a single instrument.  As noted above, the 
analysis of DNA typically requires many processing steps, with each step dedicated to a 
different instrument.  This requires manual handling and transfer of samples from 
instrument-to-instrument, which leads to contamination, sample loss and potential errors 
in reporting answers from assays in which the copy number of the input DNA is low.  (3) 
Disposable fluid handling devices that can be mass-produced at low-cost. The 
containers or reactor vials for the sample must be discarded after a single use to 
prevent sample carryover from one assay to the next potentially giving rise to false 
negatives, which is critically important in such areas as DNA diagnostics and DNA 
forensics.  At the present time, titer plates are used for sample containment, which are 
then poised on instruments that carry out the required active processing such as 
thermal cycling reactions. In the case of the electrophoretic sorting step, the processed 
samples (typically 96 – 384) are either pipetted into a well of the slab gel or 
electrokinetically injected into an array of glass capillaries. The slab gel is used once 
and discarded while capillaries are flushed after a single use and filled with fresh sieving 
matrix. 
Microfluidic chips hold the potential to allow expansion of DNA-based assays into 
a broader application base due to their ability to directly address the 3 issues cited 
above.  For example, microfluidic chips can be constructed from moldable polymer 
(plastic) materials to fabricate monolithic devices that are not only potentially low-cost, 
but can be populated with many of the processing steps required for DNA analyses on 
the same chip used to carry out the electrophoretic separation. This can create 
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functional platforms that provide high levels of automation at low cost and reduce the 
number of peripherals (i.e., instruments) built around the intended application.   
Early microfluidic efforts were focused on developing devices specifically for the 
electrophoretic step of DNA analyses and used predominately glass-based devices. 
This was spawned by glass’ high optical clarity, which accommodated nicely to optical 
fluorescence readout, and surface properties that were similar to that of capillaries, 
which allowed simple transitioning of many of the surface chemistries from capillary-
based instruments to microchips. 
In the past few years, many polymeric materials have been extensively evaluated for 
their potential use as micro-electrophoretic devices and several have been found to 
possess favorable qualities [5].  Besides the lower cost of the material, the 
manufacturing methods now available to produce plastic microfluidics allow for much 
faster production and at lower cost to meet the anticipated demands imposed by the 
clinical and forensic markets. However, it should be noted that many of the established 
surface chemistries that have functioned well for glass or fused silica, such as the 
dynamic coatings used to suppress the electro-osmotic flow (EOF) or minimize solute-
wall interactions, do not transition well to polymer-based devices due to profound 
differences in surface chemistry. In addition, the optical clarity of many polymers does 
not compare favorably to that of glass or fused silica, especially in the UV and/or visible 
region of the electromagnetic spectrum [4].      
In this review, we will focus specifically on recent progress made in the area of 
microfluidic chips for electrophoretic-based genomic analyses including genotyping, 
DNA sequencing, and forensic applications. For reviews that cover a variety of different 
biological applications of microchips we would refer the reader to [6-10].  In addition, for 
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reviews that have focused on the integration of various DNA pre-processing steps into 
the micro-separation chip, several reviews have appeared in which the reader can refer 
[11, 12]. The areas that we will discuss include genotyping applications (mutation 
scanning and mutation detection) for diagnostics, DNA forensics and finally, DNA 
sequencing. 
2.2 Genotyping: Mutation Scanning Applications  
Mutational scanning strategies are used to search for sequence polymorphisms 
in which the locus or location of the polymorphism is not known or the sequence 
variation occurs sporadically within a certain section of the genome.  Common scanning 
techniques that are used in conjunction with electrophoresis to type DNA include single-
strand conformation polymorphism (SSCP), heteroduplex analysis (HDA), denaturing 
gradient gel electrophoresis (DGGE) and temperature gradient gel electrophoresis 
(TGGE).  These methods are based on conformationally-induced mobility shifts of 
Watson-Crick matched or mismatched single or double-stranded DNA (dsDNA) 
fragments and represent an alternative to DNA sequencing, which is still impractical for 
routine clinical uses due to its relatively high cost, labor-intensive processing and slow 
turnaround time.  Moreover, scanning methods have the ability to score DNA regions 
containing large insertions and/or deletions.  Genomic interrogations of this sort are 
typically used for the detection of unknown SNPs within PCR amplified regions; 
however, vital information regarding the exact sequence location and characterization of 
SNPs are not rendered using most mutation scanning assays.  With the exception of 






SSCP is widely applied for DNA mutation scanning due to its relative simplicity 
as only PCR amplification and subsequent denaturation of the double-stranded 
amplicons to generate single-stranded DNA is required for sample preparation prior to 
the electrophoretic sorting.  Single-stranded DNA fragments, under the appropriate 
experimental conditions, possess sequence-specific 3-dimensional conformations 
resulting from intra-strand base pairing.  Heterozygous alleles have the exact same size 
as homozygotes, but possess one or more altered bases at loci that can be scored 
through conformationally-induced perturbations to the electrophoretic mobility.  Samples 
subjected to mutation scanning surveys using SSCP, and all mutation scanning assays 
for that matter, typically include the mutagenic DNA as well as their known wild-type 
counterparts from a PCR-defined region.  As such, the electrophoretic technique must 
be able to afford high resolution capabilities to observe the presence of the mutation in 
a high level of background from “normal” or wild-type DNA sequences.  
Closely following the formats adopted for SSCP analysis using slab and capillary 
gel electrophoresis (CGE), researchers have established microfluidic separation 
methods for SSCP.  For example, the first published research exploring SSCP on a 
microchip was by Tian et al. who displayed the usefulness of this platform to distinguish 
three common mutations in BRCA1 and BRCA2 genes (185delAG, 5382insC, and 
6174delT) among the Ashkenazi Jewish population, which possess high risk for breast 
cancer.  Their glass microchip profiling methodology, which paralleled a CGE method 
that was also presented in the report, used 2.5% hydroxyethylcellulose (HEC) 
containing 10% glycerol as a sieving matrix, which discriminated all mutant alleles from 
their wild-type counterparts with a four-fold reduction in analysis time (~130 s) 
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compared to the CGE separation [13].  However, they noted a substantial decrease in 
resolution in the microchip SSCP profiles and attributed it to possible inadequate 
surface passivation of the microchip using polyvinylpyrrolidone (PVP) as the dynamic 
coating for EOF suppression and a lack of adequate temperature control in the 
microchip format. 
As with the case of SSCP analysis employing capillaries, the most scrutinized 
aspect of microchip SSCP separations remains the selection of appropriate separation 
parameters to impart large mobility differences for subtle sequence variations such as 
the type of sieving matrix, stability of the additive, wall coatings, temperature, and field 
strength.  As such, parametric studies placing emphasis on these parameters have 
recently emerged.  For example, Endo and co-workers presented a systematic 
optimization of SSCP separation conditions using a glass microchip, which they 
ultimately used to probe for a set of seven p53 mutations.  Evaluating a wide array of 
sieving and glycerol concentrations, they found 1.5% methylcellulose excluding glycerol 
to be the most effective sieving matrix as the two commercial systems used (Agilent 
2100 Bioanalyzer and Hitachi SV1100) did not possess microchip cooling capabilities to 
attenuate the Joule heating produced when glycerol was present [14].  Using the 
optimized set of sorting parameters, the authors were able to analyze the full panel of 
markers in under 1 min. Kang et al. used another sieving combination (1.75% PVP, 
1.0% poly(ethyleneoxide), 5% glycerol including  0.01 - 0.025% NaOH) to enhance 
selectivity of SSCP profiles for ghrelin (childhood obesity-related) Leu72Met point 
mutations using commercial glass microchip-based instruments [15].  They were able to 
resolve the full panel of markers using the aforementioned microchip conditions in under 
85 s. A high-throughput SSCP analysis of genes associated with hereditary 
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hemochromatosis (metabolic iron storage disorder) and hypertrophic cardiomyopathy 
(heart muscle abnormality) has also been demonstrated using a 48-lane section of a 
384-lane glass-based microdevice, which yielded 100% selectivity for the 21 mutations 
being scanned [16].  The 200 mm diameter high density microchip contained 8.0 cm 
length straight channels that were radially-configured about a centered common anode.  
In this study, they performed separations in their preferred sieving material (5.0% 
polydimethylacrylamide, PDMA, 10% glycerol, 15% urea) at two running temperatures 
(25ºC and 40ºC) to realize full separation of the marker panel.  The authors also noted 
that using a delayed back biased electrokinetic injection scheme improved sample 
loading resulting in higher plate numbers and improved resolution. 
2.2.2 HDA   
HDA is an electrophoretic mutation scanning method that is based on relative 
conformational changes between heteroduplexed and homoduplexed PCR amplified 
DNA fragments.  This method differs from SSCP because it relies on differences in 
conformational structures of nearly complementary (heteroduplexed) and completely 
complementary (homoduplexed) double-stranded DNA (dsDNA) fragments instead of 
single-stranded intra-molecular folding as is used in SSCP.  Formed heteroduplexes 
contain bulges within the rehybridized DNA fragments where bases are mis-matched 
and are typically accompanied by an abundance of homoduplexes that possess 
hybridions that are fully matched (i.e., no bulges). When electrophoresing a mixture of 
homoduplexes and heteroduplexes using the appropriate separation parameters, slight 
mobility shifts between these species are often observed.  This method is often used for 
DNA species containing insertions and deletions, which typically yield more pronounced 
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mobility shifts due to significant bulges resulting from mismatched base pairs in 
duplexed DNA.   
Tian et al. first brought attention to the potential of microchip HDA separations for 
differentiating six different heterozygous breast cancer associated mutations 
(185delAG, E1250X (3867GT), R1443G (4446CG), 5382insC, 5677insA and 6174delT) 
within BRCA1 and BRCA2 genes.  This was one of the first reports of HDA separations 
in which the microchip CE method was directly compared to CGE formats [17].   The 
authors found a four- to six-fold reduction in analysis time for the microchip trials using 
the same buffer and sieving reagents as that used for CGE (1xTBE buffer with 15% 
urea, 2.5% and 4.5% HEC with 10% glycerol).  The reduced analysis time was 
associated with the use of an effective separation distance for the microchip (5.5 cm) 
that was shorter than that used for the CGE format. However, this separation channel 
length was insufficient to provide the same level of resolution incurred with the capillary 
columns.  
Another microchip-HDA study involving the detection of five BRCA1 and BRCA2 
mutations was conducted and directly compared to a denaturing (d)-HPLC method [18].  
These authors found that while the glass microchip separations could not approach the 
remarkable selectivity provided by (d)-HPLC, the microchip method could provide more 
information on different mutations within the same amplicons.  Moreover, the authors 
emphasized the microchip’s operational advantages including simplicity of the 
separation protocol, versatility and lack of sample preparation constraints.     
Due to the similarities in the electrophoretic conditions used for HDA and SSCP, 
separations of various DNA species can be performed using both HDA and SSCP 
simultaneously. The complementarity of the two is often advantageous in circumstances 
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when the selectivity of one is inadequate to score the presence of the full panel of 
potential mutations.  Therefore, most adaptations of these techniques on microfluidics 
have been performed in a tandem format.  The first microchip-based HDA-SSCP report 
of this type was given by Vahedi et al., who described an integrated on-chip labeling of 
HFE and BRCA1 amplicons with fluorescent dyes prior to separation of the 
complementary species using a commercial polymer [19].  A similar integrated 
microchip-based HDA/SSCP approach by Manage et al. was reported with the 
exception of the on-chip labeling scheme as noted for the Vahedi et al. report [20].  The 
authors detailed the profiling of three specific HFE mutations having high clinical 
relevance (C282Y, H63D, and S65C) for hemochromatosis.  The separation required a 
4 min electrophoresis development time using microchip CE.  An exhaustive study to 
elucidate the optimal parameters for glass microchip CE analyses using a combined 
HDA/SSCP method was conducted by Hestekin and co-authors [21].  They found that a 
combination of 8% w/v 600 kDa LPA and a dynamic wall-coating of poly(N-
hydroxyethylacrylamide) as opposed to a wall coating using covalent methods provided 
the best performance for p53 conformer separations, which could be completed in less 
than 10 min of electrophoresis development time.   
Diverging from the use of a combined HDA and SSCP approach, an integrated 
on-chip HDA/restriction fragment length polymorphism (RFLP) methodology was 
demonstrated. Footz et al. demonstrated the discrimination of both heterozygous and 
homozygous mutations present in the HFE gene using microchip electrophoresis, which 
the HDA method alone was incapable of detecting [22].   
To date, all HDA-related assays have been conducted on glass-based 
microchips.  For clinically-based assays that require one-time or disposable use 
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devices, transitioning these mutation-scanning electrophoresis assays to polymer-based 
chips will be critical, since polymer devices can be produced at lower cost in higher 
scale production modes compared to glass chips.  
2.2.3 TGGE and DGGE  
 TGGE and DGGE are two analogous techniques used to discriminate 
heteroduplexes containing mismatched base pairs from fully matched homoduplexes by 
continuously altering the temperature or chemical denaturant conditions in a gradient 
format during the migration of solutes through the separation channel, which affects the 
degree of dsDNA conformational stability throughout the separation process and as 
such, perturbs electrophoretic mobility.  Here, denaturing of the dsDNA is induced either 
by heating (temperature, TGGE) or imposing linear increases in chemical denaturing 
agents within the sieving gel (denaturing, DGGE) to affect the separation.  While it has 
been difficult to translate DGGE from the slab gel to micro-separation formats due to the 
inability to introduce heterogeneous denaturing conditions into the gels for the micro-
separations, TGGE has proven to be more amenable to these separation platforms, 
especially microchip CE, because of the ability to fabricate heating elements along the 
length of the entire separation column. 
  Buch et al. used a 10 channel polycarbonate (PC) microfluidic device out-fitted 
with external bulk heaters or internally tapered micro-heaters to induce spatial and 
temporal temperature gradients along the length of the separation channels for gel-
based sorting of G-C rich dsDNA fragments generated from a primary PCR.  Comparing 
the two heating configurations, they found that the integrated micro-heaters provided 
better thermal response time and more accurate control, producing better TGGE 
separations [24].  This same group later introduced a mutation scanning network 
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consisting of an integrated two-dimensional micro-electrophoretic platform, which 
combined a standard size-based gel electrophoresis separation in the first dimension 
with TGGE in the second dimension [23].  This device, which is shown in Figure 2.1, 
 
 
Figure 2.1. Illustration of the temporal temperature control setup used for microchip 
TGGE. The microchip in this case was made from polycarbonate (PC).  Reprinted with 
permission from [23]. 
 
was made from PC with external bulk heaters used to establish the temperature 
gradient along the TGGE channels.  An intermediate sample stacking strategy was 
implemented as well to reduce band broadening during sample transfer between the 
dimensions.  The 2-D separations of multiplexed SNPs varying in size and sequence 
were conducted in a development time of less than 5 min with the prerequisite 




2.3 Genotyping: Mutation Detection Applications 
 Unlike the mutation scanning techniques previously discussed, mutation 
detection methods are geared toward the identification and detection of particular 
genomic variations in which the locus is known within a certain gene.  Most assays 
associated with this class of mutations involve the use of nucleotide recognition 
enzymes including endonucleases, exonucleases, and thermostable ligases, which 
specifically cleave or bond DNA sites that harbor the mutation being interrogated.  
Several of the mutation detection assays that have been utilized for the 
identification/detection of point mutations or SNPs include allele-specific PCR (AS-
PCR), restriction fragment length polymorphism (RFLP), ligase detection reaction 
(LDR), ligase chain reaction (LCR) and single base extension assays (SBE), all of which 
depend on a high resolution electrophoretic step to sort the generated products in order 
to score the presence or absence of the mutation of interest.  Most of these types of 
assays require DNA primers that hybridize to particular locations within the genome, 
which harbor the mutation being interrogated, prior to the enzymatic reaction and as 
such, require knowledge as to the specific location of the mutation in order to design the 
appropriate sequences in the primers.      
2.3.1 Allele-Specific Polymerase Chain Reaction (AS-PCR) 
While PCR is an attractive method to amplify target DNA sequences of interest 
prior to secondary treatments such as electrophoretic analyses, the successful 
generation of PCR amplicons can be directly interrogated for scoring the presence of 
SNPs based on the use of sequence-specific primers for the PCR that are generated for 
the locus or loci being interrogated.  For example, if the PCR primers possess a 
mismatch with the target DNA, the amount of PCR product can be significantly reduced 
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or even eliminated by proper selection of the annealing temperature used in the 3-step 
thermal cycling process associated with PCR compared to fully matched 
primer/template duplexes.   Therefore, the electrophoretic sorting of PCR amplicons can 
be used to detect the mutation of interest by preceding the electrophoresis with a PCR 
step. Challenges in AS-PCR include the need for tight control on the design of primers 
and understanding their annealing temperatures (Tm), the inability to highly multiplex the 
assay and the difficulty in securing quantitative information due to the non-quantitative 
nature of most PCR-dependent assays.  
Huang et al. selected to separate gastric cancer-related SNPs using a microchip 
CE system to complement a simple-tube genotyping method, which combined a whole 
blood PCR with a tetra-PCR in which the PCR was conducted directly from 1 µL of 
unpurified whole blood or paper-dried blood [25].  Three typical genotypes of the two 
SNPs probed (IL-1B-31 and IL-1B-511) within the IL-1B gene were obtained in a 2 min 
analysis time using a commercial microchip system with its appropriate gel matrix 
(Agilent system).   
Sung et al. demonstrated the use of PMMA microchips to perform fast exclusion 
tests via PCR product profiling of fragile X syndrome (FXS) alleles based on their 
repeating unit size, (CGG)n, within the familial MR type 1 (FMR1) gene [26].  Using wire 
imprinted or hot embossed PMMA microchips filled with 1.3% or 1.8% hydroxyl 
propylmethyl cellulose (HPMC) containing an intercalating dye (TOPRO-3) to enhance 
detectability, they found that PCR bands with more than six unit repeat differences 
could be resolved in less than 3 min using a 6 cm electrophoretic separation length.   
Low-density lipoprotein (LDL)-receptor gene microsatellite alleles of the D19S394 
tetranucleotide repeat associated with familial hypercholesterolemia were sized using 
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an Agilent 2100 microchip system [27]; 17 alleles were easily distinguished using 
microchip CE, which varied from 0 – 17 repeats.  Likewise, the same instrumentation 
was used by Sohni et al. to perform routine separations for a host of PCR-amplified 
variable number of tandem repeats (VNTRs) markers indicative of diabetic and 
cardiovascular complications stemming from irregularities in several genes [28].  A 12-
lane microchip was used to detect spermatogenetic failure in a multiplexed format 
following an offline multiplexed PCR of three DNA sequence-tagged sites of interest on 
the Y chromosome [29].  With all of the required components resolved using a 1.5 cm 
effective separation channel, 36 samples could be processed within 180 s.  
A PCR study of p16 tumor suppressor gene inactivation via hypermethylation 
was also evaluated on a microchip using AS-PCR.  Comparing the ability of slab gel 
and an injection molded PMMA microchip to resolve methylation-specific PCR 
amplicons from 153 DNA plasma and tissue specimens including positive and negative 
controls, Zhou et al. found that the microchip separations yielded a 26.6% higher 
positive rate while maintaining specificity equal to that of slab gel electrophoresis [30].   
While fluorescence detection schemes are primarily used for DNA genotyping 
analyses due to its high sensitivity and low limits-of-detection as well as the ease of 
labeling fragments using fluorescently-tagged primers required for the PCR step, an on-
chip electrochemical detection strategy has also been introduced that was capable of 
detecting PCR amplicons [31].  By modifying a screen-printed carbon electrode, which 
effectively lowered the detection potential and reduced electrode fouling, unlabeled 
human heat shock factor (HSF1) gene amplicons were electrophoresed in a sieving 
matrix comprised of HEC at an optimal field strength of 200 V/cm and were detected 
with the screen-printed carbon electrodes. Some representative results from this study 
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are shown in Figure 2.2.  The assay possessed a detection limit of 584.3 fg/µL (±1.3 
fg/µL).     
 
Figure 2.2.  Elelctropherograms for the separation and detection of DNA fragments 
present in the BIONEER 1 kbp DNA standard marker (concentration = 130 ng/mL). The 
detector consisted of a modified screen-printed carbon electrode (A).  The surfaces of 
the carbon electrodes were modified with poly-5,2'-5',2''-terthiophene-3'-carboxylic acid, 
which improved the analysis performance by lowering the detection potential.  
Electrophoretic results with electrochemical detection of 30-cycle PCR products at a 
bare (B), and modified (C) screen-printed carbon electrode. The standard marker 
consisted of 500, 1000, 1610, 2000, 2961, 4025, 5007, 5991, 8029, and 10 200 bp 
fragments. The detection potential used was 10.8 V (vs. Ag|AgCl reference electrode).  
Reprinted with permission from [31]. 
 
Besides routine testing for endogenous genetic conditions of individuals for 
clinical diagnostic/prognostic applications, PCR-based approaches for the detection of 
deleterious bacterial and viral infections affecting humans have also been subjected to 
electrophoretic analysis using microchip CE.  For example, Kaigala et al. developed a 
hybrid microfluidic system for the production, detection and quantification of PCR 
products from the BK virus (BKV), a renal dysfunction highly associated with 
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transplanted kidney rejection [32].  Integrating PCR and separation processes onto 
PDMS-glass hybrid microdevices, they were able to detect as few as 1 – 2 viral copies 
as well as gauge the overall viral loads of clinical samples from renal transplant 
patients.   
Chen et al. utilized wire-imprinted PMMA microchips to screen for hepatitis C 
present in blood serum of symptomatic patients and reported the completion of 
separations one order of magnitude faster than  CGE [33].  In another study, fabricated 
PMMA microchips were also used to probe for SARS and hepatitis B virus (HBV) 
samples of known infected patients [34].  The device, containing trapezoidal imprinted 
channels transferred from a silicon master, reportedly yielded detection rates of 94.4% 
(17/18) and 80.6% (29/36) for multiplexed PCR SARS and HBV samples, respectively.   
Karasawa et al. performed microchip CE separations to detect cariogenic (tooth 
decaying) bacteria in dental plaque [35].  In this case, AS-PCR was performed to 
amplify S. mutans and S. sobrinus, both known to promote tooth decay when they 
coexist in plaque.  Comparing several mixtures of polyethylene oxide (PEO) and HPMC, 
they found 0.125% HPMC/0.6% PEO to provide the optimal mesh for the given 
amplicon sizes (202 and 226 bp, respectively). The separation of the two species was 
carried out in ~ 85 s on commercial Hitachi injection molded PMMA microchips.   
2.3.2 PCR/Ligase Detection Reaction and Ligase Chain Reaction (LDR and LCR)   
LDR is a mutation detection assay that involves the use of two complementary 
primers designed to flank a polymorphic site within the target DNA.  One primer is called 
the discriminating primer and contains the polymorphic site on its 3’ end with the allelic 
content either matching or not matching the polymorphism on the target DNA.  The 
other primer, called the common primer, is phosphorylated at its 5’ end.  Upon 
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hybridization of these primers to the target DNA, a highly specific thermostable ligase 
seals them only if there is a complete match between bases on the 3’ end of the 
discriminating primer and the polymorphic locus on the target DNA. If successful ligation 
does occur, it generates an elongated and fluorescently labeled oligonucleotide that can 
be distinguished from excess labeled unligated primers through differences in their 
sizes using electrophoretic sorting [36].  This assay is attractive because it decouples 
the PCR from the mutation detection reaction, which provides high specificity, it is 
amenable to multiplexing and it also performs exceptionally well in the presence of high 
levels of wild-type targets.  The challenge associated with this technique rests not on 
the reaction itself, but with the ability to adequately resolve, via electrophoresis, several 
short single-base differentiated oligonucleotides (<100 bp) from the labeled and 
unligated primers that can potentially mask the positive signals indicative of the 
mutations due to their much higher concentration when the copy number of the mutated 
DNA is low compared to the wild-type sequences.  Therefore, highly viscous polymers 
(8-10% polyacrylamide) are typically required to provide baseline resolution of all 
components generated from the LDR assay.   
Thomas et al. demonstrated the ability to use a hot-embossed PMMA microchip 
filled with a 4% LPA or other commercial polymers for the analysis of a 12.2 K-ras LDR 
product (44 bp), indicative of a mutation that could be associated with the onset of 
colorectal cancer [37].  The results secured from the microchip CE result were 
compared to those using a conventional CGE format using a 4% LPA gel.  CGE 
analysis of the LDR samples was incapable of providing reliable results due to 
electrokinetic injection biases; the higher concentration of the LDR primers as well as 
their higher mobility prohibited sufficient injection of the generated LDR products, 
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especially when the wild-type DNA was >100 fold higher in copy number compared to 
the mutant DNA.  The microchip CE format performed much better under these 
conditions due to the absence of electrokinetic injection biases when adopting a cross-T 
injection format.  The microchip CE separations of LDR products possessing a 100-fold 
molar excess of wild-type targets clearly showed the presence of the low copy number 
mutant alleles (well-resolved from the intense primer peaks) and required a 
development time of ~120 s in a separation channel length of only 3.5 cm [37].  In 
addition, the authors demonstrated that desalting prior to electrophoretic separation 
using microchip CE was not necessary as it was in the case for CGE. 
The LDR assay, which is carried out with temperature cycling (denaturing and 
annealing) to linearly amplify the number of generated products, is often times coupled 
to a primary PCR in which the PCR is used to amplify the gene of interest, which can 
contain severe loci harboring the mutations of interest. PCR and LDR have been 
successfully integrated onto a polymeric microfluidic device, that can be used to 
generate products for subsequent interrogation using microchip CE [38].  The reaction 
time of the coupled PCR/LDR was reduced to 6.5 min as opposed to 1.5 h required for 
conventional benchtop thermal cycling instrumentation.  
LCR is also a SNP detection method, which is based on the ligation of two pairs 
of oligonucleotide primers that hybridize to adjacent positions on complementary strands 
of a target dsDNA.  Similar to PCR, LCR exponentially amplifies target sequences, 
however, LCR differs from PCR because it amplifies only the generated probe molecule 
(ligated primers).  Moreover, LCR has been found to be more specific than PCR in 
some cases, which is prone to amplifying false positives occurring in early cycling 
events [39, 40].  The products of this application have also been detected and quantified 
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following electrophoresis on a microfluidic device.  In a study highlighting the effect of 
polymers to dynamically passivate silicon-glass microchips, Lou et al. demonstrated the 
ability to resolve LCR products of NOD2/CARD15 genes related to inflammatory bowel 
disease using microchip CE [41].     
2.3.3 Single Base Extension (SBE)  
SBE, also known as minisequencing, has emerged as an effective mutation 
detection technique to determine the allelic composition at a particular locus; it is 
considered attractive due to its simplicity as only a few major components including a 
primer, polymerase and a nucleoside triphosphate substrate are required to conduct the 
assay [42].  Moreover, the total development time of reactions is considerably short 
compared to most typing methods in terms of those requiring thermal cycling [43].  SBE 
reactions entail annealing a primer one base removed from the locus containing the 
SNP to a particular DNA template. Following hybridization, fluorescently-labeled 
dideoxynucleotides are added to the reaction and the appropriate dideoxynucleotide is 
added based on the allelic composition of the locus being interrogated.  The reaction is 
similar to conventional Sanger sequencing reactions except that deoxynucleotides are 
not included in the reaction cocktail and as such only a single base is added to the 
primer [44].  This method has been adapted to various microchip CE systems and the 
associated four-color multiplexing detection hardware associated with many CGE 
sequencing and genotyping equipment, which allows for spectral identification of the 
incorporated dideoxynucleotide.  Although SBE in conjunction with conventional CGE 
has been extensively used and reported for multiplexed SNP genotyping, few reports 
discussing SBE/microchip CE combinations have surfaced, most likely due to the 
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stringent separation performance demanded for SBE (single base resolution of short, 
~15-20 bp, DNAs).   
Vreeland et al. illustrated the novel pairing of SBE with end-labeled free solution 
electrophoresis (ELFSE) for genotyping three p53 loci using a commercial CGE system 
and discussed the potential of transitioning this strategy to microfluidic platforms [45].  
Recently, the Barron group demonstrated the microchip-based separation of 
multiplexed reactions to probe 16 p53 loci with 96% accuracy using ELFSE and 
microchip CE.  With only a denaturing buffer containing a EOF suppressant as an 
electrophoretic medium, extension units harboring 16 unique, monodispersed, 
uncharged polyamide drag-tags facilitated the size dependent separation of species 
within 70 s using a commercial glass microchip [43].   
Herbert et al. reported on an electrochemical approach for detecting mock SNP 
sites using SBE on a miniaturized platform.  The microchip CE device was composed of 
a PDMS chip aligned and sealed with a cover slip containing working and reference 
electrodes positioned near the channel outlet.  Sinusoidal voltammetry was used to 
distinguish electrochemically active extension products from unincorporated excess 
terminators following electrophoresis through agarose in less than 4 min [46].   
2.3.4 Restriction Fragment Length Polymorphism (RFLP)  
RFLP relies on the use of various endonucleases, commonly referred to as 
restriction enzymes, that cleave recognition sequences usually 4 - 8 bp in length within 
dsDNAs.  Upon treatment, DNA fragments having unique sizes corresponding to the 
distance between the restriction sites cut by the restriction enzymes are generated, and 
secondary treatments of the cleaved fragments with other restriction enzymes can 




Figure 2.3 (a) Reconstructed plot of time versus pixel number of the CCD, which was 
monitoring restriction fragments generated across the multi-channel microchip. The 
shaded bar represents fluorescence intensity collected by the CCD. The sampling 
capillary moved from right to left depositing samples into the chip, so the lane farthest to 
the right is designated as lane 1. (b) Schematic of the chip setup with capillary sample 
introduction. Laser-induced fluorescence detection was achieved by focusing an argon 
ion laser into a line across the chip 5.5-6.5 cm from the injection point.  A liquid 
nitrogen-cooled CCD was used to analyze the collected fluorescence photons.  Adapted 





electrophoretic sorting.  If a mutation or SNP exists at a particular restriction site, it can 
change the restriction patterned generated, which can be deciphered using gel 
electrophoretic sorting. The limitation associated with this mutation detection strategy is 
that the mutation loci must be contained within a restriction site. 
A high-throughput microfluidic design has been developed for the continuous 
assessment of restriction enzyme kinetics, which have been traditionally conducted 
using labor-intensive processing of millisecond-interval quenched enzymatic reactions 
and subsequently subjected to slab gel electrophoresis.  The device for this application, 
as seen in Figure 2.3, used a capillary sampling device to dispense aliquots (1 
injection/14 s) from a reaction mixture to a multi-channel (5 channels) glass chip with 
the collected fragments separated in the chip using an LPA sieving matrix and detected 
via laser-induced fluorescence with a CCD camera [47].  A 62 bp dsDNA containing a 
KpnI restriction site was used for system evaluation and the effects of temperature and 
restriction enzyme concentration were also examined.  The unique aspect of this setup 
was that the sampling device (a capillary) was not fixed to the separation platform (the 
microchip), and continuous intermittent injections could be processed in the pipeline 
without the need for completion of preceding separations, thus increasing throughput.   
The ability of microchip electrophoresis to assess restriction digests of samples 
containing low percentages of mitochondrial DNA (mtDNA) mutations in blood samples 
from diabetic patients was investigated by Guttman et al.  The assay included the 
generation of 250 and 251 bp products of a PCR-RFLP treatment designed to include a 
known ApaI site responsible for the mutation followed by the electrophoretic sorting of 
these products.  In glass microchannels filled with a 2% agarose gel containing ethidium 
bromide, they were able to routinely discriminate 1 - 2% of A324G  mtDNA point 
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mutations in mixtures containing 98 – 99% wild-type levels in less than 12 min [48].  In a 
related report, the same author introduced a high-throughput 96-lane format combining 
microfibrous membrane-mediated DNA digestion with subsequent microchip 
electrophoresis processing.  An automated spotter was used to deliver submicroliter 
quantities of target DNA and digestion enzymes from 96 well plates onto a membrane, 
which served as both a reaction vessel as well as the microchip sample 
preconcentration/loading inlet.  Results indicated that the digestions were completed 
within 1 – 10 min and subsequent separations in the agarose-filled channels (4 cm 
effective length) were completed in 5 – 10 min (20 min total analysis time) [49].  
Recently, an on-chip treatment of mtDNA employing restriction enzymes was used by 
Taylor et al. to differentiate homogeneous and heterogeneous populations of mtDNAs.  
The procedure was carried out on a straight channel 8.0 cm commercial glass chip 
(Micralyne) and included excising a mtDNA sequence from plasmid DNA via enzymatic 
digestion with EcoRI to linearize the plasmid loops into dsDNA and 
denaturing/renaturing to form duplexes of the digested DNA all taking place in a single 
sample well. The generated products were labeled with an intercalating dye (sytox 
orange) that was present in the separation matrix (Genescan polymer containing 10% 
glycerol) during electrophoretic separation (7.6 cm effective separation channel length).  
According to the authors, the method could be performed in about 45 min, whereas 
conventional methods would require days to perform this same type of assay [50].     
2.4 DNA Forensics  
The identification of humans based on DNA profiling has become a powerful tool 
in the field of forensics.  Usually, this profiling is achieved by the analysis of highly 
polymorphic variations presented in the form of short tandem repeats (STRs), which 
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consist of specific 2-7 base repeating patterns (e.g. (CAGT)n) found in the genome.  
Primarily, STRs are distributed throughout non-coding regions of the genome known as 
junk DNA with the number of repeating units typically very specific for a particular 
individual, especially when occurring at several different loci.    
Forensic DNA specimens are commonly matched to alleged criminal suspects in 
modern law enforcement using human identification systems validated according to the 
DNA Advisory Board’s (DAB) Quality Assurance Standards. These DNA testing 
systems typically involve the amplification of highly polymorphic STRs by PCR.   
AmpFlSTR® Profiler Plus and COfiler®,  Powerplex®,  Powerplex-Y, and Y-PLEX™ 12 
are examples of commonly used multiplex systems for genotyping polymorphic STRs 
residing in the human nuclear (nDNA) and male Y-chromosomal DNA.  These analyses 
are routinely performed using CGE and the genotyping capability of the ABI 3130 
automated DNA Sequencer/Genotyper instrument within forensic laboratories.  
However, prior to gel sorting, the DNA sample must be extracted from the specimen, 
typically using precipitation-type techniques, purified and then, PCR amplified.   
The resulting genetic “fingerprints” are then compared to profiles within the 
CODIS (combined DNA Index System) databank to identify a match.  The advantage of 
these types of analyses lies within the very large number of STR alleles that provide a 
very high power of statistical discrimination.  When DNA evidence is limited, analysis of 
human mtDNA targets is often employed because of the high copy number of 
mitochondria and mtDNA molecules in each cell [51].   
Forensic DNA testing is also utilized to establish the paternity of children [52].  In 
investigative forensics, DNA fingerprinting is used to infer the geographic origin of 
unknown human DNA samples [53, 54], to identify potential microbial or viral pathogens 
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for bio-defense [55] or to identify species specific source(s) of unknown trace evidence 
[56] using PCR-based analysis of a variety of genetic systems including, STRs, single 
nucleotide polymorphisms (SNPs) and mobile element insertion polymorphisms.   
The key elements of successful STR-typing include both high-resolution 
electrophoresis and precise sizing of DNA samples with respect to internal standards 
used to identify various alleles within a given locus.  The core advantages of microchip 
CE in terms of DNA forensics includes the ability to integrate sample pre-processing 
steps into a monolithic wafer and the ultra-fast separations afforded by microchip CE, 
which could play a vital role in compiling more extensive forensic databases and also, 
relieving the backlog of DNA typing cases.  For example, the cost, speed and lack of 
simple and user friendly equipment available for forensic DNA tests have contributed to 
the current backlog of over 350,000 DNA evidence samples from criminal trials.    
Work was described by Schmalzing et al. in 1997 using a glass chip possessing 
a single channel (45 µm deep and 100 µm wide) to separate single-locus and four-loci 
PCR-amplified STRs spiked with allelic standard ladders with a CE development time of 
only 30 s and 2 min, respectively, with a 4% LPA matrix under denaturing conditions 
over a 2.6 cm effective separation distance [57].  This work was later extended upon by 
using a dual wavelength LIF detection approach to increase the multiplexing capacity of 
the system to process an eight-loci STR simultaneously in a single separation channel 
[58].  A micro-variant allele present in the sample requiring single base resolution was 
resolved in 10 min using an 11.5 cm effective channel length appeared in this same 
report.   
In a subsequent study, the degree of multiplexing was further enhanced using a 
four-color excitation/detection system capable of examining 15 loci simultaneously 
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within 20 min with single base resolution ranging from 0.75 to 1 [59].  This work lead to 
the development of an STR analysis instrument designed around a 16-lane glass 
microchip CE device.  The chip layout, as seen in Figure 2.4A, included double T cross 
injectors for electrokinetic injections in each separation channel and 20 cm effective 
separation lengths that converged near the detection point to fall within the range of an 
optical scanner.  Peak accuracies of 0.4-0.9 bp were reported using the CODIS 13-
locus multiplex established by the FBI [60].   
More recently, plastic microchip CE devices have been assessed for their 
potential to accommodate high-resolution analysis of STR samples [61, 62].  In two 
related studies, polyolefin substrates having hot-embossed microchannels (4.5, 6.0, 10, 
and 18 cm long separation channels) filled with a replaceable 4% LPA matrix under 
denaturing conditions were used to electrophoretically sort common STR ladders.  
While the 4.5 cm channel was capable of providing single base resolution between 
micro-variants [61], higher quality performance was illustrated using the 10 and 18 cm 
length channels with a 3% LPA sieving matrix.  However, it was noted that pressure 
tolerances associated with these devices dictated what sieving matrix concentrations 
could be used [62].  Exceeding these pressure tolerances by pumping high viscous gels 
through the plastic channel caused release of the cover plate from the chip substrate 
and subsequent device failure.   
A high-throughput forensic study was demonstrated using a 96-lane microchip 
CE device and a 4-color radial scanning detection system.  Profiled samples attained 
using conventional CGE were analyzed in parallel for comparison followed by the 
analysis of several (17) unexamined samples using the 96-lane microchip; microchip 




Figure 2.4.(a) CAD drawing of the chip layout.  The design contained 16 lanes with 16 
double-T injectors on the right for electrokinetic sample injection.  It has a section where 
all channels are close together for scanning (arrow), the overall distance at this point is 
3.2 mm from injection to detection. (b) Complete assembly with anode on the lower left 
and the cathode board on the top right corner; there is a vial for sample inlet and 
sample waste for each lane. The effective length of each lane is 20 cm.  (c) Computer 
screen image of 6-channels of electrophoresis results for the chip system shown in (a). 
The electropherograms are from 5 data samples and one allelic ladder.  Reprinted with 




STR typing was accomplished using the PowerPlex 16® and AmpFlSTR® Profiler 
Plus® multiplexed PCR systems. Forty-eight previously analyzed single-source samples 
were accurately typed, as confirmed by an ABI Prism 310 and/or the Hitachi FMBIO II 
CGE instruments.  Minor alleles in 3:1 mixture samples containing female and male 
DNA were reliably typed as well.  
All of the aforementioned microchip-related forensic studies emphasized the use 
of STR specifically for human identification.  However, in the field of anthropology the 
ability to differentiate human remains from those of animals by sampling hair and bone 
remnants for mtDNA is sufficient.  A recent study has evaluated the usefulness of a 
microchip-processed PCR analysis using a commercial system and glass microchip for 
probing mtDNA of ancient sources [64]. Highly degraded human and non-human DNA 
samples were positively identified using a microchip CE separation by selectively 
amplifying target human-specific mtDNA genes (Cytochrome b and 16S ribosomal 
RNA).   
2.5 DNA Sequencing   
Sequencing remains the gold standard for the analysis of DNA in many 
applications such as genotyping or DNA forensics in spite of some of its current 
limitations, which mainly includes the labor intensive sample pre-processing, the slow 
development time and the high performance demands placed on the electrophoresis 
phase of sequencing.  The quest to design microchip CE for demanding DNA 
sequencing applications as part of the HGP spawned the production of elaborate units 
featuring dispersion-limiting channel turn geometries to extend channels within a small 
footprint for increased DNA read lengths, offset injection crosses to increase sample 
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injection plug volumes to aid in detection and multi-lane formats for high throughput 
analyses.   
The pioneering report for transitioning sequencing CGE separations to 
microfabricated CE chips was presented by Woolley et al. in 1995; the electrophoresis 
was conducted on a simple, straight-channel (50 µm wide, 8 µm deep) microchip 
channel etched into glass wafers filled with a polyacrylamide gel [65].  With an effective 
separation distance of 3.5 cm, four-color DNA sequencing traces of ~150 bp were 
performed with 97% base calling accuracy in only 540 s.  Improvements upon this work 
followed refining subsequent platforms to improve both resolution and throughput.  
Ultimately, high density (96-lane) CE microchips with deeper (30 µm) and longer (15.9 
cm) effective separation lengths that were radially-configured into a common anode 
were developed, which increased the average read length to 430 bases [66].  While this 
particular microfluidic device was initially intended for sequencing, it has been utilized in 
some of the previously mentioned high throughput genotyping and forensic applications 
as well [63].   
After a stringent parametric study of micro-electrophoretic sequencing 
separations in terms of channel lengths and sieving gel concentrations [67], work by 
Aborn et al. introduced an automated microchip CE sequencing system employing 384-
channel microdevices with channel lengths varying from 37 - 45 cm situated on large 
glass plates (25 cm x 50 cm).  The device was capable of providing 800 base read 
lengths and called 1.72 x 105 bases per 384-lane run with 99% accuracy [68].    
Although sparingly reported, plastic-based microfluidics has also been employed 
for DNA sequencing.  Boone et al. reported four-color sequencing reads of 640 bases 
with 98% accuracy using an acrylic microchip bearing an 18 cm embossed channel 
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within 30 min [69].  Using polyolefin microchips with much shorter channels (4.5 cm), 
Shi et al. demonstrated the ability to read a sequence to 320 bases with 99.1% 
accuracy within 13 min [61].  In both studies, replaceable LPA matrices were used for 
sieving. 
Along with the miniaturized sequencing separation platforms, auxiliary 
components have been incorporated into the microchip CE system to aid in the 
separation and detection.  For example, Ueberfeld et al. used a solid support sample 
loading technique to minimize the obstacles associated with the processing of low 
concentrations of DNA sequencing fragments typically encountered using microfluidic 
devices (see Table 2.1).  By directly injecting Sanger DNA sequencing samples 
reversibly adsorbed onto paramagnetic microspheres and extraction from solution with 
a magnetized wire, they were able to achieve fluorescence signal intensities that were 
equal to that of standard offset T injectors having >10 times the initial DNA sample 
content [70].   
Also of interest are efforts in microchip CE for potentially simplifying the DNA 
separation phase of the sequencing processing pipeline by developing alternative 
electrophoretic separation mechanisms that could potentially eliminate the necessity of 
using sieving materials such as polymer gels and their associated high viscosity 
constraints.  Using the previously mentioned ELFSE technology [72], ~110 base 
sequencing read lengths have been reported using conventional capillary 
electrophoresis in ~18 min [73].   
Researchers are now pushing towards the production of highly integrated 
sequencing units to perform sample preparation and cleanup prior to the electrophoretic 





Figure 2.5. (a) Photograph of the integrated microchip device, showing one of two 
nucleic acid processing systems. Colors indicate the location of sequencing reagent 
(green), capture gel (yellow), separation gel (red), and pneumatic channels (blue).  (b) 
High-quality sequencing data generated using the integrated bioprocessor shown in (a). 
Sanger sequencing extension fragments were generated from a 750-bp pUC18 PCR 
amplicon. Automatic base calls were secured by the program PHRED and base 
numbers are indicated above the electropherogram. Scale bar is 5 mm in (a).  Reprinted 




Recently, a fully integrated microchip bio-processing unit combining temperature 
cycling, sample purification and electrophoretic separation has been fabricated, which 
contained nanoliter-scale reaction chambers.  Shown in Figure 2.5 is the system, which 
consisted of a glass-PDMS hybrid device capable of performing complete Sanger 
sequencing on 1 fmol of DNA template with read lengths of up to 556 bases and a 
calling accuracy of 99% [71].   
2.6 Conclusions 
Significant strides have been made toward demonstrating the potential of planar 
microchip devices as viable miniaturized electrophoretic platforms for the separation of 
DNAs for a variety of different and important applications. Over the past decade, 
pioneering proof-of-principle separations of both single-stranded and double-stranded 
DNAs as well as enzymatically produced DNA products on primarily glass substrates 
have produced highly promising separations that offer the advantages of shorter 
electrophoretic development times compared to their slab gel and capillary counterparts 
without significant sacrifices in terms of separation resolution.  While progress in 
microchip CE separations of DNA samples have been reported, significant advances 
and improvements in this technology platform still must be made to allow its permeation 
into clinical laboratories for diagnostics and forensic laboratories for DNA typing.  For 
example, the development of lab-on-a-chip systems that incorporate all of the sample 
pre-processing steps into the system incorporating an electrophoretic separation would 
provide fully automated analyses with little manual or operator intervention or expertise, 
minimize sample contamination and allow permeation of this promising technology 
platform into a broader user community.   
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Another area that must evolve is significant reductions in the cost of producing 
microfluidic chips for CE-based separations and even those chips that consist of 
multiple processing steps to allow full automation of the DNA processing pipeline. This 
will be particularly important in forensic and diagnostic applications, where disposable 
fluidic components are demanded.  Replication technologies of plastic microfluidic 
devices can provide an array of ideal fabrication techniques for producing low-cost 
electrophoretic and other DNA processing chips.  Transitioning glass and fused silica-
based techniques to polymeric materials will facilitate the evolution of disposable 
microfluidic cartridges for such applications. 
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Chapter 3:  Capillary and Micro-Electrophoretic Separations of Ligase Detection 
Reaction Products Produced from Low Abundant Point                             
Mutations in Genomic DNA 
3.1 Introduction 
 Electrophoresis can be utilized in screening assays for the diagnosis of 
presymptomatic disease states, such as the early detection of cancers, which can arise 
from the accumulation of mutations in certain gene fragments that may be inherited or 
somatic, caused either from exposure to environmental factors or from malfunctions in 
DNA replication or repair machinery.  These mutations can then be used as markers in 
a variety of different electrophoresis formats, such as heteroduplex analysis, single 
strand conformational polymorphism analysis, denaturing gradient gel electrophoresis 
or DNA sequencing.   
One example where electrophoresis can potentially provide diagnostic 
information is the early detection of colorectal cancers using the identification of point 
mutations in the human K-ras oncogene, which manifest themselves primarily as single 
base-substitutions located at two bases in codon 12, two bases in codon 13 and three in 
codon 61.  These particular mutations occur in 35 – 50% of all colorectal adenomas and 
can manifest themselves early in the development of colorectal neoplasms [1-4].  Once 
acquired, these mutations are preserved throughout disease development and thus, 
have great utility for diagnostic testing. 
Unfortunately, the detection of these mutations is complicated by the fact that 
often their presence is masked by significant amounts of wild-type sequences even at 
the primary tumor site, which can contain a majority of wild-type stroma.  The frequency 
of the mutated allele at the primary tumor site can be as little as 15% for heterozygous 
samples and this number goes down precipitously if the sampling is done away from 
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this site.  Therefore, improvements in early detection and treatment of cancer patients 
depends intimately on rapid and accurate high throughput methodologies capable of 
identifying low abundant mutations with high selectivity.   
 K-ras mutations may be detected by direct DNA sequencing, allele specific 
oligonucleotide hybridization or restriction digestion techniques [5-8].  Others have used 
high sensitivity techniques such as phage cloning, allele-specific PCR or repetitive 
restriction digestion to detect K-ras mutations in stool or lymph nodes of cancer patients 
as indicators of micrometastases [9-15]. Unfortunately, these techniques have intrinsic 
limitations, such as low sensitivity (DNA sequencing) or the inability to detect the full 
spectrum of K-ras mutations (restriction digestion or allele-specific PCR).  Furthermore, 
allele-specific amplification techniques are prone to false positives generated from 
minute contamination or from the introduction of point mutations by polymerase errors 
during extension.     
A slab gel-based electrophoretic assay has recently been reported for the 
detection of mutations associated with colorectal cancer using a ligase detection 
reaction (LDR) [16], a method that simultaneously amplifies DNA and identifies single 
base mutations in a multiplexed format [17].  LDR is based on an allele-specific ligation 
of two synthetic oligonucleotide primers, which flank the point mutation (a common and 
discriminating primer) that hybridize to one strand of the target DNA as shown in Figure 
3.1.  The junction point of these primers is selected so that the nucleotide at the 3’ end 
of the discriminating primer coincides with the single base mutation site in the target 
sequence.   The discriminating and common primers are covalently joined to form an 
LDR product by a thermostable ligase only if the nucleotide at the potential mutation site 




Figure 3.1. Diagram illustrating the ligase detection reaction and the LDR primer sizes 
used for human K-ras gene mutation discrimination at site 12.2 of codon 12 within exon 
1.  Discriminating primers were fluorescein-labeled on their 5’ ends. The length of the 
discriminating primer and the corresponding amino acid abbreviations are indicated; V = 
valine, A = alanine, D = aspartic acid. 
 
The process is multiplexed using electrophoresis to screen the full spectrum of 
point mutations associated with a particular disease via size discrimination by varying 
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the base numbers of the discriminating primer used for the LDR assay as shown in 
Figure 3.1 [16].  Generation of an LDR product indicates the presence of a mutation 
while the length of the LDR product designates which mutation was present (allelic 
composition or mutation location in the gene).  In the example shown in Figure 3.1, the 
wild-type sequence contains a cytosine (C) nucleotide in the K-ras gene at position 
12.2, which codes for the amino acid glycine during translation.  Possible mutations at 
this site, the resulting amino acid substitution, and their respective abbreviations are 
adenine (A) / valine (V), guanine (G) / alanine (A) and thymine (T) / aspartic acid (D).  
Thus, a G12V mutation corresponds to a glycine-to-valine change at codon 12 resulting 
from a base substitution of G with A. 
Using two discriminating primers and one common primer, a slab gel assay was 
able to detect one mutation in 4,000 wild type sequences at a 9 to 1 signal-to-noise ratio 
[18]. Using an eight-primer set (six discriminating primers and two common primers) 
designed to detect two possible mutations in codon 12, the assay was able to detect 
one mutation in 1,000 wild-type sequences at a signal to noise ratio of 3 to1.  The same 
mutation was detected in 500 wild-type sequences using an entire 26 primer set (19 
discriminating primers and 7 common primers) designed to probe for 19 possible 
mutations at codons 12, 13 and 61 simultaneously.  Unfortunately, the slab gel assay 
required several hours of electrophoretic development time to adequately resolve the 
LDR products from excess unligated primers.  
 In this paper, we wish to report on the use of capillary and microchip 
electrophoresis formats for detecting single base mutations in selected gene fragments 
(K-ras) using LDR.  Several issues must be considered when developing capillary or 
microchip electrophoresis platforms for LDR analyses.  In the standard LDR assay, a 
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large excess of primer over the target template ensures efficient hybridization and 
ligation.  Due to the large amount of primers contained within the reaction cocktail, the 
electrophoretic method must be able to resolve the LDR product from this excess, both 
of which contain a fluorescent label.  In addition, single base resolution is required since 
the size of the product, as deduced from the migration time, is used to identify the 
particular mutation site and/or its allelic composition.    
Capillary gel electrophoresis (CGE) can provide a method for the rapid analyses 
for LDR-based assays using a variety of different separation matrices to provide 
sufficient resolution to detect the LDR product, even at low abundance.  However, a 
concern associated with this method is the well-characterized injection bias, in which 
high mobility species, such as short primers and salts, are loaded preferentially 
compared to slower migrating components.  Therefore, high resolution must be 
achieved so as not to mask the LDR products in the large band generated from 
unligated primers when these are much higher in concentration [19].  In addition, 
injection biases can severely limit the loading of the LDR products, demanding high 
sensitivity detection as well.  A final concern is the oligonucleotides that must be 
separated, which are single stranded DNAs (ssDNA) with a size range <100 bps and as 
such, special requirements are demanded for the sieving matrix to provide the 
necessary selectivity.   
The microdevice format can potentially allow rapid analyses and reduced 
consumption of reagents, issues that are important for high throughput screening 
applications [20].  Compared to CGE, microelectrophoresis can provide more 
representative loading of all fragment sizes through unbiased volume-based injections 
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[21].  However, these devices also contain shorter separation lengths that have the 
potential to limit resolution unless high resolving power gels are used. 
Using a K-ras mutation in codon 12 as a model, capillary and microdevice 
electrophoresis methods were developed to demonstrate the ability for analyzing point 
mutations in K-ras genes of low abundance with electrophoresis.  Several ssDNA 
separation matrices in the capillary and microdevice format were evaluated in a 
modeling study using synthetic dye-labeled oligonucleotides for their ability to analyze 
low copy numbers of long oligonucleotides (LDR products) in an excess of shorter 
oligonucleotides (unligated primers).  Using the optimized conditions and separation 
matrices in both electrophoretic formats, PCR products generated from cell lines of 
known K-ras genotype were used as templates for LDR to detect single base mutations 
in codon 12.   
3.2 Methods and Materials 
3.2.1 Capillary Electrophoresis Instrumentation 
CGE separations were performed using a Beckman P/ACE System 5510 
(Beckman Instruments, Fullerton, CA).  Data acquisition was performed using the 
Beckman P/ACE software.  Detection was accomplished using the appropriate laser-
induced fluorescence (LIF) module fitted into the CE instrument, which contained an 
Argon ion laser (λex = 488 nm) and a 520 nm emission filter placed in front of the 
photomultiplier tube.  In all cases, the electrophoresis was performed in a reverse 
mode, with the detection end anodic and the injection end cathodic. 
3.2.1.1 Capillaries and Sieving Matrices 
PAGE-5 (5%T, 5%C) polyacrylamide gel-filled capillaries (referred to herein as 
5T5C) and buffer were purchased from Agilent Technologies (Palo Alto, CA).  The total 
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capillary length was 36 cm while the effective length was 30 cm; however, this length 
varied slightly from run to run due to clipping of the inlet end of the capillary prior to 
each run to restore column performance.   The electric field strength was set to 250 
V/cm at an operating temperature of 25 C.  A water pre-injection of 10 s at 10 kV was 
used to increase sample loading.  Typical injection times ranged from 10 s to several 
minutes as indicated in each electrophoretic trace.   
The eCap ssDNA 100-R Gel (herein referred to as eCap), buffer and neutrally 
coated capillary (75 m i.d.) were purchased from Beckman Coulter (Fullerton, CA).  
The optimized separation conditions for the eCap were found to be 308 V/cm at 30 C.  
The matrix was replaced in the capillary (30 cm effective length, 36 cm total length) prior 
to each run at approximately 800 psi using a pressure vessel designed in-house.   
The Performance Optimized Polymer (herein referred to as POP5) and buffer 
were obtained from Applied Biosystems (ABI, Foster City, CA).   The optimized field 
strength for this gel was determined to be 215 V/cm while the capillary temperature was 
set to 50 C.  A bare fused silica capillary (75 m i.d., 30 cm effective length, 36 cm total 
length) was filled with POP5 using approximately 1,000 psi pressure before each run.  
3.2.2 Microdevice Fabrication and Assembly 
The microdevice consisted of a 10 cm separation channel with 0.5 cm side 
channels to the sample, buffer and waste reservoirs as shown in Figure 3.2A.  The 
microchannel was hot-embossed in poly (methyl methacrylate) (PMMA) (MSC, Melville, 
NY) using a Ni mold master containing microstructures 80 m tall and 20 m wide 
(channel dimensions) that were produced by a LIGA process as described elsewhere 
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[22].  The final device was assembled by annealing a PMMA cover plate to the open 
face of the device at 109 C in a circulating air oven for 15 min.  
3.2.3 Laser-induced Fluorescence (LIF) Instrumentation   
The LIF microdevice detection system was constructed in-house with an 
epillumination configuration, as shown in Figure 3.2B.  The system consisted of a 488 
nm air-cooled argon ion laser (Omnichrome, Model 532), which was directed to the 
focusing objective using a multimode fiber optic and a dichroic mirror.  The excitation 
beam was focused using a 16X microscope objective (Melles Griot) onto the 
microdevice, which was situated on an X-Y-Z microtranslational stage in order to 
position the microchannel with respect to the focused laser beam.  The fluorescence 
emission was filtered though a stack of optical filters and focused onto a single photon 
avalanche diode (SPAD, Model SPCM-AQ-141, EG&G Optoelectronics Canada, 
Vaudreuil, Canada).  The filter stack consisted of a 520 nm bandpass filter (Oriel, 
Stratford, CT) and a 520 nm long-pass filter (Edmund Scientific, Barrington, NJ).  The 
LIF signals were acquired on a personal computer using a 16-bit counter/timer board 
(Model AT-MIO-16XE-50, National Instruments, Austin, TX). 
3.2.3.1 Microelectrophoresis Operation   
Labview software and an electrophoretic “switch box” constructed in-house were used 
to control voltages during the microelectrophoresis.  The device included three internal 
high voltage power supplies (EMCO) capable of receiving input of 0 or +5 V from DAC 
(digital to analog converter) outputs of a PCI-MIO-16XE-50 board (National 
Instruments).  These power supplies delivered 0 to +2 kV to wells (A) and (B) (EMCO 





Figure 3.2.  (A) The geometrical layout of the microelectrophoresis chip, which was 
fabricated using hot embossing from a Ni master in PMMA.  The chip contains four 
reservoirs, A = sample; B = waste; C = buffer and D = buffer waste.  The chip contained 
a separation channel that was 10 cm in total length with a channel width of 20 µm and 
depth of 80 µm.  (B) Also shown is an annotated picture of the laser-induced 
fluorescence system used for detection on the microchips. 
  
During injection, a positive voltage was applied to the waste well (B) (see Figure 
3.2A) while the sample well (A) was grounded.  During separation, a positive voltage 
was applied to well (D), (C) was grounded and “pullback voltages” were applied to the 
sample (A) and waste (B) reservoirs to prevent leakage of extraneous material into the 
separation channel.  The microdevice was first manually filled with separation matrix.  
Following filling, the buffer and sample reservoirs were filled with the appropriate 
material.  Once filled with the sieving matrix, the gel was pre-conditioned by 
electrophoresing for 5 min at 100 V/cm (voltage applied between reservoirs (C) and (D), 
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see Figure 3.2A). For the electrophoretic separation, the optimized field strength for the 
appropriate sieving gel was used as well as the appropriate pullback voltages on the 
sample and waste reservoirs.  In all cases, the electrophoresis was performed in a 
reverse mode with the injection end cathodic and the detection end anodic. 
3.2.4 Modeling Primers and DNA Sizing Ladder   
All primers used in this work were obtained from Integrated DNA Technologies 
(IDT, Coralville, IA) with PAGE purification and fluorescein labeling of the discriminating 
primers at their 5’ ends.  The fragments used as models were constructed to mimic 
common and discriminating primers as well as LDR products and consisted of 25, 44 
and 51 bp fragments of random sequence.  Using the 25 base primer to represent the 
unligated primers, model samples representing 1:10, 1:100 and 1:1,000 molar ratios of 
LDR product to unligated primers were prepared.  In each sample, the unligated primer 
(25 bp) was maintained at 1.0 M and for the 1:10, 1:100 and 1:1,000 modeling 
samples, the 44 and 51 bp synthetic LDR products were 100.0 nM, 10.0 nm and 1.0 
nM, respectively.   
3.2.5 LDR Primers   
Primers used for LDR were purchased from IDT with fluorescein labeling on their 
5’ ends (discriminating primer).  LDR primers were designed for identification of single 
base substitutions in codon 12.2 by altering the length of each primer as shown in 
Figure 3.1.   When analyzing the G12V allele, the discriminating primer for G12D was 
included in order to monitor potential misligations of the discriminating primer used to 
detect the G12D genotype, representing a C:A mismatch in wild-type DNA.  The three-
primer set consisted of two discriminating primers and one common primer as shown in 
Table 3.1.  
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Table 3.1.  LDR discriminating and common primers.  Primer size and sequence are 
indicated.  * = common primer, which was phosphorylated at its 5’ end to allow ligation. 
Primers Size Sequence 
Fluor-K-ras c12.2V  26 5’ Fluor-CAA AAA CTT GTG GTA GTT GGA GCT GT 3’ 
Fluor-K-ras c12.2A 25 5’ Fluor-CAA AAC TTG TGG TAG TTG GAG CTG C 3’ 
Fluor-K-ras c12.2D 24 5’ Fluor-AAA ACT TGT GGT AGT TGG AGC TGA 3’ 
K-ras c12 Com-2* 20 5’ pTGG CGT AGG CAA GAG TGC CT 3’ 
   
 
3.2.6 DNA Extraction from Cell Lines   
PCR products were amplified from genomic DNA that was extracted from cell 
lines of known K-ras genotype (HT29, wild-type; G12V or G12D mutant alleles) [16].  
Cell lines were grown in RPMI culture media with 10% bovine serum.  Harvested cells 
(~1 x 107) were resuspended in DNA extraction buffer (10 mM Tris-HCl, pH 7.5, 150 
mM NaCl, 2 mM EDTA, pH 8.0) containing 0.5% SDS and 200 μg/mL proteinase K and 
incubated at 37ºC for 4 hr.  Thirty-percent (v/v) of 6 M NaCl was added to the mixture 
and the samples centrifuged.  DNA was precipitated from the supernatant with 3 
volumes of EtOH, washed with 70% EtOH and resuspended in TE buffer (10 mM Tris-
HCl, pH 7.2, 2 mM EDTA, pH 8.0). 
3.2.7 PCR Reagents and Conditions   
PCR amplifications were carried out in 50 μL with 10 mM Tris-HCl buffer (pH 8.3) 
containing 10 mM KCl, 4.0 mM MgCl2, 250 μM dNTPs, 1 μM forward and reverse 
primers (50 pmol of each primer), and between 1 and 50 ng of genomic DNA extracted 
from the cell lines as described above.  The set of primers used were:  Ex.1.3 forward = 
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5’ AAC CTT ATG TGT GAC ATG TTC TAA TAT AGT CAC 3’; Ex.1.4 reverse = 5’ AAA 
ATG GTC AGA GAA ACC TTT ATC TGT ATC 3’; Ex.2.9 forward = 5’ TCA GGA TTC 
CTA CAG GAA GCA AGT AGT 3’ and Ex.2.11 reverse = 5’ ATA CAC AAA GAA AGC 
CCT CCC CA 3’.  After a 1 min denaturation step, 1.5 units of Amplitaq DNA 
polymerase (Perkin Elmer, Norwalk, CT) was added under hot start conditions and 
amplification was achieved by thermally cycling for 35 - 40 cycles at 95ºC for 30 s; 60ºC 
for 1 min; 72ºC for 1 min and 72ºC for 3 min for a final extension.  PCR products were 
stored at –20ºC until required for use. 
3.2.8 LDR Reagents and Conditions   
LDRs were carried out using conditions similar to those published elsewhere 
[16].  Briefly, the PCR products were used as templates for the ligase reaction.  The 
appropriate ratio of wild-type to mutant sequence was added to a solution containing 1X 
Tth ligase buffer (10 mM Tris-HCl (ph 7.6), 10 mM MgCl2, 0.1 M KCl and 20 μg/mL 
bovine serum albumin), 10 mM DTT, 1.25 mM NAD+ (nicotinic adenine dinucleotide, a 
cofactor for ligase enzyme) and 500 nM of each discriminating primer taken to a final 
volume of 20 L.  The mixture was heated to 94 C for 1.5 min prior to adding 1 nM Tth 
DNA ligase (received from Cornell).  LDRs were thermally cycled 20 times at 94 C for 
15 s and 65 C for 4 min.  Reactions required cleanup prior to CGE using a cold ethanol 
precipitation to reduce the amount of salts.   This was carried out by adding 7 µL of 7 M 
NaOAc and 100 µL of 100% cold ethanol to the LDR.  The solution was vortexed and 
placed in a refrigerated centrifuge for 30 min at 10,000 rpm at 4oC.  The supernatant 
was removed and the reactions thoroughly dried in a Centro-Vap (Brinkman 
Instruments, Westbury, NY, USA) for 1 hr.  The DNA pellet was then reconstituted in 
ddH2O (10 µL) and vortexed for 1 min prior to CGE.  
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3.3 Results and Discussion 
3.3.1 LDR Modeling Samples Using CGE   
Modeling samples were made using synthetically generated DNA fragments 
labeled on their 5’ ends with fluorescein to mimic LDR- generated products in the 
presence of excess LDR primers.  The fluor-K-ras C12.2A (25 bp) oligonucleotide was 
used at 10, 100 and 1,000 times molar excesses of the synthetic LDR products (44 and 
51 bp oligonucleotides).  Considering a sample of one mutated DNA for every 20 wild-
type sequences and an LDR cocktail consisting of  three discriminating primers (500 
fmol each – 1,500 fmol total) and 20 thermocycles, the enzymatic reaction can  
Table 3.2.  Results from model studies of an LDR assay using 5T5C, eCap and POP5 
matrices with CGE.  Efficiency (plate numbers, N) was calculated for the 25 (unligated 
primer model), and the 44 and 51 bp fragments (ligation product models).  Resolution 
was calculated between the 25 bp and 44 bp oligonucleotides as well as for the 44 and 
51 bp LDR product models. 
 
potentially yield 500 fmol of LDR product if 100% ligase efficiency is achieved using 
optimal conditions.  Because 500 fmol of discriminating primer (one allele) are 
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consumed in the reaction, this results in a 1:2 ratio of LDR product to discriminating 
primer (500 fmol LDR product to 1,000 fmol discriminating primer).  In an 1:1,000 
(mutant:wild-type) sample, LDR should produce ~1:150 molar excess of discriminating 
primer.  If the ligation efficiency per cycle is lower than 100%, the ratio of LDR product 
to unligated primers is much lower than that calculated here. 
Modeling samples were analyzed under optimized conditions for CGE using the 
5T5C capillary, the POP5 separation matrix and the eCap matrix.  Efficiencies (plate 
numbers) were calculated for the 25 bp discriminating primer as well as the 44 and 51 
bp synthetic LDR products.  Resolution was calculated between the discriminating 
primer and the 44 bp product, as well as between the 44 and 51 bp products. These 
results are summarized in Table 3.2. 
3.3.1.1 5T5C Analysis Using Synthetic Models 
Using the 5T5C capillary, injection times required to load sufficient amounts of 
the 44 and 51 bp products were 20 s, 45 s and 75 s for the 1:10, 1:100 and 1:1,000 
LDR product model to discriminating primer (25 bp) molar ratio, respectively.  Baseline 
separation of all fragments was achieved in less than 45 min as shown in Figure 3.3 for 
the 1:100 modeling sample.  In some cases, efficiencies were better than 1 x 106 m-1, 
but in no case was it less than 1 x 105 m-1.  Inspection of the results shown in Table 3.2 
indicated that the plate numbers decreased for the 25 bp oligonucleotide with 
decreasing amounts of the 44 and 51 bp ssDNAs due to the longer injection times used.  
This resulted in reduced resolution between the 25mer and 44mer.  However, the 
opposite trend was generally observed for the 44mer and 51mer, with higher plate 
numbers observed as the molar ratio of 25mer to the 44/51-mers was increased.  
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A difficulty encountered when using this gel was the rapid rate of column 
degradation, which appeared to be a result of longer injection times required to load 
sufficient amounts of the longer oligonucleotides of lower concentration for detection.  In 
addition, since the gel could not be removed from the capillary, the entire capillary 
needed to be replaced following column failure.  Manufacturer supplied information 
reported lifetimes greater than 20 hours.   However, in our case, we found that we could 
perform only 10 separations before the capillary displayed significant degradation in 
performance (~10 h of operation).  
 
 
Figure 3.3.  Analysis of a 1:100 modeling sample using the 5T5C gel. The capillary 
column was 36 cm in length (30 cm effective length) and it was maintained at 25ºC with 
a run voltage of 9 kV and the sample was injected for 45 s at 10 kV.  
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3.3.1.2 eCap Analysis   
Analysis using the eCap gel column provided baseline resolution of all fragments 
in less than 30 min.  Similar trends in plate numbers and resolution were observed for 
this gel matrix as that found with the 5T5C gel (see Table 3.2), with higher excesses of 
the 25mer producing reductions in the resolution between the 25mer and 44mer as well 
as smaller plate numbers for the 25mer. The model LDR products were well resolved in 
the 1:10 and 1:100 samples (R = 4.56 and 7.40, respectively) and discrimination was 
possible from the excess primer as shown in Figure 3.4 for the 1:100 sample. 
 
 
Figure 3.4.  Analysis of a 1:100 modeling sample using the eCAP gel. The neutrally 
coated eCAP capillary was run at a voltage of 11.1 kV with the capillary maintained at 
30 ºC.  Electrokinetic injection was 20 s at 10 kV.   
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Interestingly, we were unable to load sufficient amounts of the 44 or 51 bp 
oligonucleotides when the 25mer was in 1,000-fold molar excess even when using 
electrokinetic injection times up to 5 min.  This may indicate that severe injection biases 
occurred using this eCap matrix as compared to the 5T5C capillary.   As such, 
analyzing samples with high molar ratios of short oligonucleotides cannot be 
accomplished using this linear polyacrylamide gel.  
3.3.1.3 POP5 Analysis   
Analysis using the POP5 separation matrix was also able to separate 
electrophoretically the LDR models and discriminating primer at the 1:10 and 1:100 
molar ratios (see Figure 3.5 for the 1:100 sample).  As can be seen from inspection of 
Table 3.2, the POP5 gel generally provided less plates and poorer resolution for these 
short ssDNAs compared to the eCAP and cross-linked gels.  Severe loss in resolution 
and efficiency resulted in subsequent injections if the matrix was not replaced after each 
run.  Injection times were 5 and 45 s for the 1:10 and 1:100 samples, respectively, while 
injections of up to 5 min were unable to load sufficient amounts of the LDR models for 
the 1:1,000 sample, similar to that observed for the eCAP gel.  
3.3.2 CGE analysis of PCR/LDR Samples   
Considering the severe injection biases encountered for injecting samples 
electrokinetically with high molar excesses of unligated primers using the eCap and 
POP5 separation matrices, LDR samples were analyzed using the 5T5C capillary, the 
results of which are shown in Figure 3.6 (1:100 G12V mutant to wild-type) and Figure 
3.7 (1:1,000 G12V mutant to wild-type).  In all cases, the LDRs were cold ethanol 
precipitated to remove excess salts prior to capillary injection to assist in loading the 




Figure 3.5.  Analysis of a 1:100 modeling sample using the POP5 matrix. The capillary 
column was 36 cm in length (30 cm effective length).  The POP5 analysis of 1:100 
modeling sample consisted of a bare silica capillary with a run voltage of 7.7 kV and 





Figure 3.6.  Analysis of a G12V 1:100 (mutant to wild-type) LDR sample.  
Electrophoretic conditions were the same as those listed in Figure 3.3 for the 5T5C 
column except that injection was for 40 s.   
  
increased to 90 s for the 1:1,000 sample.  With decreasing amounts of mutant template, 
resolution between the LDR product and unligated primers decreased similar to our 
model studies.  The loss in resolution resulted from increased loading of the unligated 
primers due to the longer injection times required and the biased injections favoring 
loading of the shorter oligonucleotides.  In both cases, the analysis required 36 min to 
generate sufficient plates to resolve the LDR product from unligated primers. For the 
1:100 mutant to wild-type sample, the resolution between the unligated primers and  
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LDR product was calculated to be 3.14 and decreased to 1.51 in the 1:1,000 sample. 
 
 
Figure 3.7.  Analysis of a G12V 1:1,000 (mutant to wild-type) LDR sample. 
Electrophoretic conditions were similar to those for the 5T5C column in Figure 3.5 
except injection was for 90 s. 
3.3.2.1 Optimization of Electrophoretic Conditions Using Modeling Samples and 
Microelectrophoresis  
 
The matrices (linear entangled polymers and cross-linked gels) were problematic 
for the detection of point mutations using LDR in the capillary format due to severe 
injection biases, which required desalting of the LDR prior to gel loading.  These 
injection biases were particularly problematic when the mutant strands were significantly 
lower in abundance compared to the wild-types. Injection biases could potentially be 
minimized in a microelectrophoretic format by incorporating cross “T” injectors that 
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provide volume-based injections free from significant electrokinetic biasing effects.  In 
addition, the smaller formats associated with microchip electrophoresis could allow 
higher sample throughput by reducing electrophoretic development time.  Therefore, we 
evaluated the feasibility of using a polymer-based microelectrophoresis chip for 
analyzing LDR samples containing gene fragments of low abundance with point 
mutations of clinical significance.    
We investigated three different gel matrices for use with the PMMA microchip; 
POP5, eCAP and a 4% linear polyacrylamide (LPA) containing 7 M urea as the 
denaturant.  In the case of the eCAP and LPA matrices, the PMMA microchip was used 
without a coating to suppress its intrinsic electroosmotic flow, which has been measured 
to be 1.4 x 10-4 cm2/Vs [22].  The POP5 gel contains a buffer, which suppresses the 
EOF in conventional capillaries (fused silica), but the ability of this buffer to suppress the 
EOF in polymer-based microchips has not been demonstrated.  To test each matrix, an 
equal molar solution of the 25 and 51 bp synthetic oligonucleotides were 
electrophoresed in the microchip using an effective separation length of 3.5 cm.   In all 
cases, the separations were performed at room temperature using an electric field 
strength of 113 V/cm.  The 4% LPA matrix provided the best resolution between these 
synthetic oligonucleotides with R = 1.64, while the POP5 and eCAP matrices provided 
resolutions of 1.20 and 1.19, respectively.  In all three cases, baseline resolution was 
achieved for these short single-stranded oligonucleotides, but the 4% LPA matrix 
provided the highest resolution, which should make it appropriate for analyzing the 
ligated products when the copy number of the mutants is significantly lower than the 
wild-types. The plate numbers for these gels were comparable (~3.5 x 105 m-1) 
indicating that the enhanced resolution observed for the 4% LPA matrix was due 
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primarily to its higher selectivity for these short oligonucleotides. The injection conditions 
used in these examples was 35 s using 500 V applied between the sample (A) and 
waste (B) reservoirs (see Figure 3.2A).   
For the eCAP and LPA matrices, the PMMA separations were performed in 
uncoated microchannels producing acceptable results in terms of plate numbers and 
migration times.  Recently, it has been reported that successful DNA sequencing of 
short tandem repeats (read lengths < 400 bp) can be obtained in polymer-based 
microchips of 4.5 cm in length, but a coating procedure was required to secure 
favorable results [23].  The coating procedure, which was used specifically to suppress 
the EOF of the microchip, consisted of 2% w/v poly-
dimethylacrylamide/diethylacrylamide in water, with a 2 h incubation time.  Our results 
indicate that for the separation of short oligonucleotides as in the present case, no 
coatings for EOF suppression are required for PMMA microchips.  However, inclusion of 
EOF suppression coatings may be necessary in these chips for longer oligonucleotides 
due to their smaller apparent electrophoretic mobilities.  In addition, the results obtained 
by the eCAP and POP5 gel were similar in terms of their plate numbers and migration 
times indicating that the POP5 gel and buffer system may not possess dynamic coating 
capabilities in polymer microchips as they do for fused silica capillaries. This conclusion 
is not too surprising given the differences in surface chemistries between these 
materials.   
Care was taken to optimize the injection conditions as well to prevent significant 
band broadening resulting from sample leakage into the separation channel while at the 
same time allowing complete filling of the fixed volume injector of the shorter 
oligonucleotide (ie, LDR product).  It was found that injections less than 15 s (using a 
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500 V injection voltage) were insufficient for entirely filling the injection cross with the 
sample while injections longer than 25 s resulted in excessive band broadening as 
noticed by reductions in plate numbers.  Using optimized injection conditions (tinj = 20 s; 
V = 500 V) and an effective separation length of only 3.5 cm provided sufficient plate 
numbers (N = 1.51 x 106 and 1.67x 106, for the 25 and 51 bp oligonucleotides, 
respectively) to adequately resolve the generated LDR product from unligated primers 
even when the mutant allele was in low copy number compared to the wild-type.   
3.3.3 Microchip Electrophoresis of LDR Samples       
In Figure 3.8 (A) and (B) are shown the microelectrophoretic results of an LDR 
reaction containing the G12D mutant sequence only (A) and the wild-type only (B).  
Also, a 1:100 molar ratio of mutant to wild-type alleles are shown in Figure 3.9.  In all 
cases, the LDR reaction was loaded directly into the appropriate reservoir of the chip 
without subjection it to a desalting procedure.   As can be seen, in the case of the wild-
type only one peak appears in the electropherogram most likely arising from unligated 
primers.  In the case of the mutant allele, a new band appears at longer migration times 
compared to the primer peak, resulting from a successful ligation of the common and 
discriminating primers producing a 44 bp product in this case. 
In Figure 3.9 is shown the results of a ligation assay where the wild-type allele was 100-
fold higher in concentration compared to the mutant allele.  Using these electrophoretic 
conditions, the LDR product could be resolved from unligated primers in under 120 s 
with a resolution of 1.3, approximately 17-times faster than that observed using CGE 
(see Figure 3.6) with only a slight reduction in resolution.  
  Microchip separations of two LDR mutations (G12D and G13D) generated in a 




Figure 3.8.  Microelectrophoresis analysis of the G12D LDR product.  (A) G12D mutant 
LDR sample with no wild-type sequences, (B) the wild-type control sample (no mutant 
sequences).  The electrophoresis was run using a 4% LPA sieving matrix with 7 M urea 
as the denaturant. The matrix was conditioned by pre-electrophoresis at 1 kV for 5 min.  
The sample was injected for 20 s at 500 V and electrophoresed at 113 V/cm using 
pullback voltages on the waste and sample reservoirs of 210 and 350 V, respectively.  






















Figure 3.9.  Microelectrophoresis analysis of a 1:100 mutant (G12D) to wild-type ratio.  
The electrophoresis was run using a 4% LPA sieving matrix with 7 M urea as the 
denaturant. The matrix was conditioned by pre-electrophoresis at 1 kV for 5 min.  The 
sample was injected for 20 s at 500 V and electrophoresed at 113 V/cm using pullback 
voltages on the waste and sample reservoirs of 210 and 350 V, respectively.  The 
effective channel length was 3.5 cm (total length 10 cm).  
   
were later conducted with a custom, moderately viscous polymer solution composed 
sparsely cross-linked ultra-high molar mass polyacrylamide “nanogel” [24].  The 
polymer was reconstituted in 1xTTE buffer containing 7 M urea to a 2.75% (w/v) 
concentration.  As seen in Figure 3.10, using a field strength of 125 V/cm and the same 
detection length of 3.5 cm, both LDR products for the 1:10 abundance ratio could be 
resolved within ~4.5 min. Similarly the PMMA microchip separation of the 1:100 ratio 
LDR sample, which is within range of biologically relevant levels, was successful.   
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Figure 3.10.  PMMA microchip separation using a 2.75% (w/v) nanogel for the sorting 
of multiplexed LDR of G12D and G13D products at an abundance ratio of 1:10 (mutant 
to wild-type) sample.  The polymer was reconstituted in 1xTTE buffer containing 7 M 
urea.  The separation was conducted at 125 V/cm after a 35 s injection at 350 V/cm with 
a detection length of 3.5 cm. 
 
As seen in Figure 3.11, using the same parameters as listed for the microchip 
separation of the 1:10 LDR sample in Figure 3.7, both products were present after ~4.5 
min of development time. 
 3.4 Conclusions 
Several ssDNA separation matrices for CGE were evaluated for their ability to detect 
low abundant point mutations using LDR.  The eCap and POP5 replaceable matrices 
provided successful separation of model LDR products at 1:10 and 1:100 molar ratios to 
the synthetic unligated model primers with sufficient resolution in less than 35 min, but 
with lower resolution compared to the 5T5C cross-linked gels.  The eCap matrix  
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Figure 3.11.  PMMA microchip separation using a 2.75% (w/v) nanogel for the sorting 
of a multiplexed LDR of G12D and G13D products at an abundance ratio of 1:100 
(mutant to wild-type).  Run conditions were the same as those listed in Figure 3.7. 
 
required a neutrally coated capillary to suppress the EOF or prevent solute-wall 
interactions, which would adversely affect electrophoretic efficiency.   The POP5 gel 
provided dynamic coating capabilities of the capillary that permitted use of a bare fused 
silica capillary with no pretreatment necessary.   While these gels provided baseline 
resolution for these model LDR samples of relatively low molar excess of unligated 
model primers, they suffered from severe injection biases and appeared inadequate for 
the detection of samples containing an 1,000-fold molar excess of unligated primer.  
Under the conditions listed here, sufficient loading of the LDR products was not 
possible.   
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The 5T5C cross-linked capillary provided analysis of molar ratios up to 1:1,000 of 
LDR product to unligated primers with better resolution and efficiency as compared to 
the eCap and POP5 matrices; however, increased column deterioration resulted from 
unusually long injections required to sufficiently load LDR products.  The covalent 
bonding of the polyacrylamide to the capillary wall prevented matrix replacement. 
Microchip electrophoresis using uncoated polymer substrates demonstrated 
potential for providing rapid analyses of LDR products.  The volume-based injection 
associated with these formats have been shown to provide representative loading of 
various sized DNA fragments where electrokinetic injection in capillaries are subject to 
biases favoring high mobility fragments and salts [21].  Initial microdevice separations 
using a 4% LPA separation matrix were favorable in providing high efficiency 
separations with adequate resolution in the size range of interest in as little as 120 s, 
nearly 17-times faster than capillary gel formats.  In addition, sample processing prior to 
the electrophoresis was simplified by eliminating the need of desalting using ethanol 
precipitation or other similar techniques. 
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*Reprinted with permission from Electrophoresis.    [91]   
Chapter 4:  Ligase Detection Reaction Mutation Screening via Free Solution 
Electrophoresis in a Polymeric Microfluidic Device* 
4.1 Introduction  
The stochastic nature of molecular alterations during tumorigenesis makes 
cancer diagnosis and prognosis using molecular profiling an arduous task.  Cancers 
often possess multiple mutations embedded within several different genes with varying 
frequencies; in most cases, these mutations must be thoroughly probed to accurately 
identify the presence or risk of developing a particular phenotype.  For example, 30-
50% of all colorectal adenomas are marked by the presence of one or more of the 19 
known mutations found in the K-ras oncogene alone [1-4].  Most K-ras mutations are 
localized to codon 12 and to a lesser extent, codons 13 and 61; these mutations are 
well preserved throughout tumor progression.  Testing for these mutations is difficult 
because the percentage of cells with mutated DNA fluctuates greatly with respect to the 
stage of tumorigenesis and the location and proximity of the sampling site with respect 
to the primary tumor site [5-10].  For example, colorectal cancer (CRC) sampling of 
plasma samples from CRC patients found only 0.01% to 1.7% of the 47,800 APC 
molecules collected per mL of plasma contained mutant alleles [11].  Even at the 
primary tumor site, the predominant cells are normal  stromal cells (wild-type; WT) 
found at levels as high as 70% [12].  Successful and accurate genotyping for CRC 
therefore not only depends on the utilization of a multiplexed analysis format, but also 
the ability to detect low copy numbers of mutated sequences in a vast sea of WT DNA.    
One technique that can distinguish low abundant mutant DNA from WT DNA in a 
multiplexed format is the ligase detection reaction (LDR) coupled to a primary PCR [13-
20].  Following PCR amplification of the appropriate genes containing the loci of 
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interest, the amplicon is mixed with two complementary primers (a common primer and 
discriminating primer) that flank the mutation locus of interest. Conventionally, the 
discriminating primer contains a base at its 3’ end that coincides with the single-base 
mutation site.  Facilitated by a highly specific thermally stable ligase, the two primers 
are covalently joined to form an LDR product if and only if the nucleotide at the potential 
mutation site is complementary to the 3’ end of the discriminating primer. This process 
then linearly amplifies LDR products during subsequent thermal cycles; the products 
that correspond to the presence of a mutation are approximately twice as long as the 
original LDR primers.  The flexible design of this primer ligation-based scheme has 
allowed successful LDR implementation onto DNA microarrays as well as 
electrophoretic sorting platforms [12, 13, 21]. 
Typically, stringent measures have been required to sort products generated 
from LDRs, including cross-linked slab gels or capillary gel electrophoresis (CGE), 
which typically require >1 h to achieve separations with adequate resolution [13].  
Recently, microchip electrophoresis has successfully been used to score the presence 
of mutations using LDR [22].  The use of microchips as a miniaturized electrophoretic 
platform allows reduced analysis times and provides a platform for integration of front-
end molecular processing to realize an autonomous lab-on-a-chip system, which can 
reduce the potential for sample contamination and expand the user base of genetic 
molecular analyses due to the automated nature of sample processing.  Using 
inexpensive polymeric substrates for the fabrication of the fluidic elements will 
dramatically reduce the overall cost of the analysis and make these platforms viable for 
one-time use diagnostic applications [21, 23-27]. 
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An obstacle for the translation of capillary-based electrophoretic technologies to 
microchips is the highly viscous sieving gels required for size-dependent separation of 
DNA.  Viscous media lengthen the preparation and separation times and limit the 
electric field strength that can be used and also demand robust devices to fill the 
channels.  Gel loading devices and port assemblies constructed to address these 
issues have had moderate success, but the relatively low pressures that microchips and 
assembly interconnects can sustain make these solutions tenuous [28].  Furthermore, 
maintaining the integrity of the assembled microchip becomes more difficult as pressure 
drops increase due to increases in channel length for improvements in separation 
resolution and multi-channel designs for high-throughput applications [29].  The use of 
polymer-based electrophoresis exacerbates this problem due to their inability to 
withstand high gel loading pressures.  Moreover, the chemical composition and/or 
concentration of the sieving matrix must often be modified to accommodate only a 
limited size range of DNAs to be sorted [30].   
In efforts to circumvent the necessity of sieving matrices for DNA separations, 
end-labeled free solution electrophoresis (ELFSE), also referred to as free solution 
conjugate electrophoresis (FSCE), was theorized and later demonstrated [31-33].  
FSCE is an attractive separation technique for sorting charged biopolymers without the 
need of a sieving medium.  In FSCE, a monodisperse, uncharged polypeptide or 
polypeptoid “drag-tag” is conjugated to DNA to disrupt the free-draining behavior of 
DNA in an electric field [33].  In this regime, the size of the DNA determines its 
electrophoretic driving force, which is countered by the frictional and hydrodynamic drag 
from the appended drag-tag.  The conjugates of DNA and drag-tags can then be 
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separated by size using electrophoresis in free-solution (with no polymer matrix 
present); the molecular weight and other properties of the drag-tag determine the length 
of DNA that can be separated with single-base resolution by FSCE possible. With the 
size range of monodisperse drag-tags now available, DNA separations of ~180 bases 
have been demonstrated and this electrophoretic approach has proven useful for 
sequencing and also single base extension (SBE) genotyping with free solution 
separations performed in both capillaries and glass microchips [34-36].   
Here, we present the combination of LDR and FSCE (LDR-FSCE) to create a 
novel, multiplexed electrophoretic method to screen low-copy number mutations (in a 
high abundance of WT DNA) using  poly(methyl methacrylate), PMMA, microchips 
without a sieving matrix.   Because the desired fragment lengths of LDR products in 
addition to their fluorescent probes are relatively small and require single base 
separation performance (42 – 46 bp), a combination of viscous matrices and relatively 
long column lengths are usually needed to sort them.  In our previous work involving 
PMMA microchip separations of LDR products, a few commercially available polymer 
matrices optimized for capillaries and glass microchips were investigated [22].  Although 
effective, none exhibited the degree of performance required to separate multiple LDR 
products in this particular size range.  In LDR-FSCE, LDR primers were conjugated to 
polypeptoid drag-tags to efficiently resolve fluorescently-labeled LDR products 
generated from K-ras mutations with a high diagnostic value for CRC [37, 38].  Using 
this FSCE approach, rapid separations (~85 s) of LDR/drag-tag conjugates (LDR-dt) 
were achieved in PMMA microchips using only a Tris-based buffer containing an 
electroosmotic flow (EOF) suppression additive.    
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4.2 Methods and Materials 
4.2.1 DNA Template Preparation  
Genomic DNA was extracted from cell lines of known K-ras oncogenic 
expression associated with the onset of CRC (HT-29, wild-type; SW1116, G12A; 
SW620, G12V; LS180, G12D; and DLD1, G13D) (ATCC, Manassas, VA) using a 
Qiagen DNeasy kit (Valencia, CA).  Here, the nomenclature of the given mutations (i.e., 
G12D) denotes the DNA base substitution (G) within a particular codon (12; GGT) in 
exon 1 of the K-ras gene, which alters the amino acid translation from glycine to 
aspartic acid (D).  PCR amplifications were carried out to generate 290 bp amplicons of 
each template in 50 μL volumes containing 10 mM Tris-HCl buffer (pH 8.3, 10 mM KCl, 
4.0 mM MgCl2), 250 μM dNTPs, 1 μM forward and reverse primers (50 pmol of each 
primer), and between 1 and 50 ng of genomic DNA extracted from the cell lines.  The 
gene-specific primer sequences were;  exon 1.3 forward - 5’ AAC CTT ATG TGT GAC 
ATG TTC TAA TAT AGT CAC 3’  and exon 1.4 reverse - 5’ AAA ATG GTC AGA GAA 
ACC TTT ATC TGT ATC 3’.  After a 2 min initial denaturation, 1.5 units of AmpliTaq 
DNA polymerase (Applied Biosystems, Foster City, CA) was added under hot-start 
conditions and amplification was achieved by thermally cycling for 35 cycles at 95ºC for 
30 s, 60ºC for 1 min, 72ºC for 1 min with a final extension at 72ºC for 3 min. 
4.2.2 Drag-tag Synthesis and Primer Conjugation  
The synthesis of the four, linear poly N-methoxyethylglycine (NMEG) drag-tags 
(length = 20, 32, 44 and 56 monomers) utilized in this study (see Figure 4.1) was 
achieved using a solid-phase submonomer synthetic protocol, which has previously 
been described in detail and was accomplished using an ABI 433A automated peptide 
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synthesizer [39, 40].  All drag-tags were capped with an N-terminal maleimide and 
purified to monodispersity by RP-HPLC.  The discriminating primers used for the LDRs 
were purchased from IDT (Coralville, IA) and contained a C-6 spacer and thiol linker 
modifications on their 5’ terminus to facilitate the attachment of the drag-tags (see Table 
4.1).  Common primers were synthesized bearing either FAM (excitation/emission = 
492/517 nm; IDT) or IRD-800 (excitation/emission = 780/816 nm; LI-COR, Lincoln, NE) 
fluorescent labels (z) on their 3’ ends with phosphorylation on their 5’ termini (see Table 
4.1).  The thiol groups on the discriminating primers were reduced by incubating the 
primers with a 20x molar excess of TCEP, tris(2-carboxyethylphospine; Acros Organics, 
Morris Plains, NJ) in pH 7.2 100 mM sodium phosphate buffer at 40ºC for 90 min. The 
drag-tags were conjugated to the 5’ termini of the discriminating primers using a 1:20:28 
primer:TCEP:drag-tag concentration ratio in pH 7.2 100 mM sodium phosphate buffer 
that was incubated at room temperature for 3 h [35].  The largest polypeptoid drag-tags 
(56 monomers) were paired with the corresponding smallest discriminating primers 
(21bp), and vice versa, to generate the greatest possible resolution between the LDR 
products (see Table 4.1) [35]. 
4.2.3 LDR of Drag-tag/DNA Primer Conjugates   
LDR assays were carried out using conditions similar to those described 
elsewhere with slight modifications [22].  Briefly, appropriate ratios of the 
aforementioned WT and mutant amplicons were added to a solution containing 1x Taq 
DNA Ligase buffer (20 mM Tris-HCl, 25 mM potassium acetate, 10 mM magnesium 
acetate, 10 mM dithiothreitol, 1.0 mM NAD) at pH 7.6 (New England Biolabs, Beverly, 
MA) and 25 nM of each discriminating and common primers taken to a final volume of 
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20 L with ddH2O.  After an initial 2 min denaturation at 94ºC, 40 U of Taq DNA ligase 
(New England Biolabs) was added to the cocktail under hot-start conditions and the 
reactions were thermally cycled 20 times for 15 s at 94ºC and 2 min at 65ºC.  The 
reaction was then quenched by rapid cooling to 4ºC followed by the addition of 0.5 mM 
EDTA.  Prior to electrophoretic analyses, samples were desalted using CentriSep spin 
columns (Princeton Separation, Adelphia, NJ).   
 
Table 4.1.  Design of Primers for LDR-ELFSE. 
 
4.2.4 Microchip Fabrication 
Microchips were fabricated using methods previously developed and reported by 
our group [41].   Briefly, the procedure involved machining a molding die by milling 
raised microstructures onto a brass plate.  These microstructures formed a separation 
channel with dimensions of  70 m (depth) x 30 m (width) and 9.5 cm in length (total) 
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with 0.5 cm intersecting side channels offset by 500 µm, which provided a defined 105 
pL volume for sample injection. These microstructures were embossed into PMMA 
wafers (MSC, Melville, NY) using an embossing system consisting of a PHI Precision 
Press model number TS-21-H-C (4A)-5 (City of Industry, CA) and a vacuum chamber 
connected to the press to remove air (pressure < 0.1 bar).  The microchannel pattern 
was transferred into a PMMA wafer at 155°C and 1000 lb for 4 min.  After hot-
embossing, the press was opened and the polymer wafer was cooled to room 
temperature.    Reservoirs were added to the microchips by drilling 1.25 mm holes 
centered at the end of each channel.  After an ethanol rinse and sonication in ddH2O for 
debris removal, the final device was assembled by annealing a PMMA cover plate to the 
open face of the device by clamping between glass plates (~10 lb) and heating to 107 C 
in a circulating air oven for 20 min.  
4.2.5 Laser-induced Fluorescence (LIF) and High Voltage Control System 
A laser-induced fluorescence (LIF) detection system was constructed in-house 
with an epi-illumination configuration.  A diode 780 nm laser filtered with a band-limiting 
line filter (Thorlabs, Newton, NJ) was directed onto a dichroic mirror, which reflected the 
excitation beam through a 40x microscope objective (Newport, Fountain Valley, CA) into 
the microchannel, which was situated on an X-Y-Z micro-translational stage.  The 
fluorescence emission was filtered through a filter stack and focused onto a single 
photon avalanche diode (model SPCM-AQR-12, Optoelectronics, Vaudreuil, Canada).  
The filter stack consisted of an 825 nm bandpass filter (Oriel, Stratford, CT) and an 800 
nm long-pass filter (Edmund Scientific, Barrington, NJ).  The LIF signals were acquired 
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on a personal computer using a 32-bit counter/timer board (Model PCI-6601, National 
Instruments, Austin, TX).   
A custom Labview program was used to control applied voltages for the 
microchip electrophoresis.  The unit included three internal high voltage power supplies 
(EMCO, Sutter Creek, CA) capable of receiving inputs of 0 or +5 V from a DAC (digital-
to-analog converter) output of a CYDDA 04P board (CyberResearch, New Haven, CT).  
These power supplies were capable of delivering 0 to +2 kV to sample and waste 
reservoirs (EMCO Model C20, Sutter Creek, CA) and +0.3 to +5 kV to the anodic 
reservoir (EMCO Model G50), all of which could be dynamically altered throughout the 
separation.   
4.2.6 Capillary and Microchip LDR-FSCE Conditions 
Separations of the LDR products were performed on an ABI 3100 (Applied 
Biosystems) using 36 cm (47 cm total separation length) capillaries filled with 1x TTE 
(89 mM Tris, 89 mM TAPS, 2 mM EDTA) and 7M urea buffer containing 0.5% (v/v) 
POP6 (Applied Biosystems) to dynamically coat the capillary walls to suppress the EOF.  
Samples were electrokinetically loaded into the capillaries by applying 43 V/cm for 20 s 
and electrophoresed at 320 V/cm.  For the microchip analysis, separations were 
performed at room temperature using microchannels filled with 1x TTE (50 mM Tris, 50 
mM TAPS, 2 mM EDTA) and 7M urea buffer containing 0.05% (w/v) methyl 
hydroxyethyl cellulose, MHEC, (Sigma Aldrich, St. Louis, Mo) to dynamically coat the 
PMMA channel walls for EOF suppression [42].  To generate a volume-defined injection 
plug, 347 V/cm was applied for 50 s from the sample reservoir (ground) to the waste 
reservoir (+ 3.5 kV).  Electrophoresing of the sample was conducted using 365 V/cm, 
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while adduction field strengths of 345 and 276 V/cm were applied to sample and waste 
reservoirs, respectively, to prevent extraneous sample leakage into the separation 
channel.    
4.3 Results and Discussion 
4.3.1 LDR-FSCE Genotyping 
In order to conduct FSCE separations of LDR products, LDR primers were 
reconfigured to allow for the addition of drag-tags onto the 5’ terminus of the 
discriminating primers.  LDR primers intended for electrophoretic separation in a sieving 
medium are typically designed with discriminating primers bearing fluorescent labels on 
their 5’ termini [18].  In this case, LDR primer sets were modified in a similar manner to 
those previously used for microarray studies [12].  As illustrated in Figure 4.1 and Table 
4.1, the fluorescent label was placed on the 3’ terminus of the common primer, which 
also contained a 5’ phosphorylation modification to facilitate covalent coupling of the two 
primers in the event of a successful ligation event due to primer complementarity with 
the mutant allele.  A thiol group was positioned on the 5’ terminus of the discriminating 
primers, which served as the reactive site for drag-tag attachment.   
LDR assays were initially performed using thermocycling conditions and primer 
concentrations previously optimized for conventional primer-based procedures to 
establish LDR parameters suitable for drag-tagged primers.  To verify successful 
conjugation of the drag-tag with the thiolated oligonucleotides as well as the ability to 
generate LDR products without interferences stemming from drag-tag presence, single 
primer set positive control reactions (4) were conducted consisting of one drag-tagged 
modified discriminating primer (G12D-dt, G12A-dt, G12V-dt, and G13D-dt, see Table 
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4.1) and its respective dye-labeled common primers with individual K-ras mutant 
templates.  In addition, the same reactions were performed with discriminating primers 




Figure 4.1.  Diagram showing the generation of drag-tagged LDR products and their 
subsequent separation profile from a mixed population of these LDR-dt products.  LDR 
primers having single base differences upon successful ligation are inversely paired 
with drag-tags of different sizes (largest drag-tag to smallest ligated-primer pair).  Under 
an electric field, each LDR-dt conjugate has a unique electrophoretic mobility in free 
solution whereas the non-conjugated primers have a mobility that is independent of 
size.  Larger LDR-dt products having greater overall charges migrate faster than LDR 




4.3.2 CE Analysis of the LDR-dt Products 
FSCE separations of the LDR-dt control samples were conducted using an ABI 
3100 system for optimizing the LDR-dt reaction parameters.  Figure 4.2 shows the 
successful generation of LDR-dt products for all four K-ras mutant templates.  As can be 
seen, all LDR-dt products were effectively resolved from excess dye-labeled common 
primers, which tended to mask LDR products due to their much higher concentration.  
The FSCE separation required ~11 min.  Each product possessed a unique 
electrophoretic mobility yielding resolutions between the dye-labeled common primer 
and LDR-dt products of 4.33, 6.54, 8.50, and 12.27 for the G12V-dt, G12A-dt, G12D-dt 
and G13D-dt products, respectively.  As expected, the relative migration times of the 
LDR-dt conjugates corresponded to the size of the drag-tag units appended to the given 
LDR-dt products in that the LDR-dt product with the largest drag-tag eluted last and that 
with the smallest drag-tag eluted first (See Table 4.1).   
In a direct comparison, the separation of the non-drag-tagged G12D LDR sample 
is shown in Figure 4.2.  In this case, no LDR product was visible after the separation as 
the LDR product co-migrated with the unincorporated labeled common primers in free 
solution, thus illustrating the pronounced effects of drag-tags on the mobility of the LDR 
products.  However, the presence of a G12D LDR product was illustrated upon the 
separation of the sample using gel electrophoresis (data not shown), but required a 
development time of ~36 min with a resolution of 3.14 [22].   
It was discovered that extending the denaturation time during the LDR cycling 
beyond 2 min at 95ºC lead to partial hydrolysis of the maleimide linker between the 




Figure 4.2.  Free solution CAE electropherograms of positive control samples and 
multiplex LDR-dt samples that are probing four K-ras mutations.  Four positive control 
LDR assays consisting of each mutagenic template paired with its respective 
discriminating (drag-tagged) and common primer. A negative control LDR assay 
excluding drag-tags was conducted and analyzed via FSCE for comparison.  The 
reactions consisted of 1 nM of each mutagenic template with 25 nM each of the 
common and discriminating primers per reaction in 1x Taq ligase buffer and 40 U Taq 
ligase (20 µL total reaction volume).  Thermocycling conditions included 20 cycles of 
95°C for 20 s and 65°C for 2 min following a 2 min initial denaturation at 95°C.  
Electrokinetic injections and separations were performed in 1x TTE buffer containing 7 
M urea and 0.5% POP6 (for EOF suppression) at E = 416 V/cm for 10 s for injection 
and E = 375 V/cm for the separation. 
 
slight mobility shifts.  During initial experiments, the relative peak areas indicated that 
LDR products generated for G12D and G13D mutations, which are the most commonly 
found K-ras mutant alleles, were approximately 20-fold greater than LDR products 
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generated for the less frequently occurring G12A and G12V mutations [43].  To increase 
their visibility in the electropherograms in subsequent results, the relative amount of 
G12A and G12V LDR-dt products were enhanced by increasing their genomic template 
concentrations from 50 pmol to 100 pmol prior to PCR amplification.  Additionally, 
subsequent reactions were performed by adding the drag-tagged discriminating primers 
after the initial denaturation step used in the LDR phases of the assay to minimize 
primer-dt degradation.  Also, it was determined that the incorporation of drag-tags did 
not appreciably affect the melting temperature of the LDR primers by comparing product 
yields from experiments performed at different annealing temperatures (data not 
shown). 
Once optimal conditions were established for the LDR-dt assays, a single-tube 
multiplexed reaction was conducted using FSCE for sorting the LDR-dt products.  The 
reactions consisted of concurrent generation of all K-ras amplicons (multiplexed PCR) 
from which a measured aliquot was then LDR cycled with a mixture containing all four 
drag-tagged discriminating primers (100 nM each) and two common primers (50 nM 
each) to demonstrate the ability of this mutation detection scheme to probe mutations 
within the same locus or having close proximity with high fidelity.  The electropherogram 
depicted in Figure 4.3 shows the separation of the simultaneously generated LDR-dt 
products whose unique migration times approximately matched those established in the 
initial control experiments.  Likewise, the relative peak areas for G12D and G13D 
mutant alleles were approximately 10-fold greater than the G12A and G12V mutant 





Figure 4.3.  Free solution CAE electropherograms of positive control samples and 
multiplex LDR-dt samples that are probing four K-ras mutations.  A FSCE separation of 
four K-ras LDR-dt products generated simultaneously in a single-tube reaction using the 
entire panel of mutant templates and LDR primers (see Table 4.1 for sequences). The 
reaction and run conditions were the same as listed in Figure 4.2. 
 
4.3.3 PMMA Microchip LDR-dt Separations 
PMMA microchip FSCE separations of positive control samples were performed 
using the described in-house constructed LIF and high voltage control system.  Two 
important factors that must be considered when using polymer microfluidic devices as 
electrophoretic platforms for genotyping are the pressure tolerance of the device and 
the ability to manage the EOF of the polymer substrate surface, which sometimes varies 
from batch-to-batch in different feedstocks of PMMA.  Here, both issues were 
addressed through the use of free solution electrophoresis, which eliminated the need 
[106] 
 
for pressurized introduction of highly viscous sieving media into the microchannels of 
the devices and a dynamic EOF suppression coating, which required the inclusion of 
0.05% MHEC (w/v) in the running buffer, well below its entanglement threshold [42].  
EOF measurements for the PMMA microchip showed that the running buffer containing 
MHEC attenuated the EOF to 1.49 ± 0.07 x 10-5 cm2/V s, which was consistent across a 
number of different PMMA chips and one order of magnitude lower than that obtained 
for untreated PMMA microchips (1.77 ± 0.11 x 10-4 cm2/V s). 
Figure 4.4 illustrates the separation of K-ras LDR-dt products using a PMMA 
microchip.  Similar to the capillary separations, the results for each mutant allele were 
baseline resolved from the free dye-labeled primers.  The separations using the PMMA 
microchips were completed in ≤ 85 s with an effective separation length of 3.5 cm and a 
field strength of 365 V/cm, which provided resolution values of 2.13, 2.32, 2.77, and 
3.25 between the dye-labeled common primer and LDR-dt products G12V-dt, G12A-dt, 
G12D-dt and G13D-dt, respectively. As many as five consecutive separations could be 
performed on the same microchip without requiring replenishment of the sample or 
changing the buffer used for the electrophoresis.  No carryover contamination from run-
to-run was observed when adduction voltage fields were applied to the sample reservoir 
during injection.  Using these parameters, migration times were highly reproducible 
(e.g., Tm= 81 s ± 1.8 s for G12D-dt) over five successive runs as well as for chip-to-chip 
trial analyses.     
 Microchip FSCE separations of multiplexed LDR-dt samples were also 
conducted for the simultaneous detection of all four mutant alleles.  The experiment was 




Figure 4.4.  Microchip FSCE separations of positive control K-ras LDR-dt reactions.  
The custom-micro-milled PMMA microchip was hot embossed from a brass master (9.5 
cm length, 30 µm width and 70 µm depth) utilized to separate the LDR-dt products 
generated using the same conditions given in Figure 4.2.  The volume-defined cross 
injection (105 pL) and separation were performed in 1x TTE containing 7 M urea and 
0.05% MHEC (for EOF suppression) at E = 365 V/cm for 50 s (injection) and E = 375 
V/cm for the electrophoretic separation.  Typical analyses used an effective channel 





      
Figure 4.5. Microchip FSCE separation of a multiplexed LDR generating LDR-dt 
products.  Following PCR of the mutagenic K-ras loci in a single-tube reaction, a 
multiplexed single-tube LDR was conducted using the conditions stated in Figure 4.2 
with an increase in genomic DNA for G12A and G12V templates to 100 pmol prior to 
PCR.  The effective channel separation length was 6 cm and E = 450 V/cm were 
selected to optimize the resolution of all LDR-dt products. The other separation 
conditions were indentical to those described in Figure 4.4.  
 
and G12V template quantities were increased from 50 pmol to 100 pmol prior to PCR 
amplification in order to provide peak intensities similar to the predominant G12D and 
G13D alleles.  As seen in Figure 4.5, all four LDR-dt products were separated within 
~165 s using a field strength of 450 V/cm at an effective distance of 6.0 cm to provide 
near baseline resolution of all products.  At this high field strength, no physical 
alterations of the microchannels were observed under magnification as well as no 
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deleterious effects on separation performance in terms of plate numbers due to Joule 
heating.    
In order to evaluate the ability to score the presence of these mutations when 
present in low abundance compared to the WT alleles, LDR-dt assays were conducted 
using G12D and G13D K-ras mutants at biologically relevant levels (1 mutant copy per 
100 WT copies) by adding 5.0 nM WT template to 0.05 – 5.0 nM of mutant templates to 
construct 1:1, 1:10 and 1:100 excesses of mutant-to-WT samples.  LDR-dt products 
were visible in the electropherograms for both K-ras mutant templates at levels up to 
1:100 at a SNR = 7.1 (see Figure 4.6).  Attempts to detect LDR-dt products lower than 
1:100 were not successful due to the detection limit of the LIF system and 
electrophoretic masking resulting from the high peak intensities of the unligated 
fluorescently-labeled primers.  A negative control reaction excluding the K-ras mutant 
templates conducted for 5.0 nM WT DNA showed no visible peaks indicative of the 
formation of misligated products.  Thus, there is minimal probability that this LDR-FSCE 
assay will give false positive results.  The PCR/LDR technique is capable of maintaining  
high specificity in low abundance conditions due to: i) the thermostable ligase, which 
has the ability to rapidly dissociate from junction sites containing mismatches; and ii) 
early misligation events are not further amplified [13].  For example, in the case of 
amplification techniques based on allele-specific PCR, fluorescent mutant sequences 
are directly produced, which can generate false positives from misincorporations of 
nucleotide bases by the polymerase.  Here, the PCR serves only to amplify target DNA 
sequences and the presence of mutations within these DNA sequences are discerned 
by a follow-up allele-specific ligation.  
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Figure 4.6.  Microchip FSCE separations of multiplexed K-ras LDR-dt reactions probing 
the G12D and G13D mutant alleles with changes in the relative abundances of wild-type 
alleles with respect to the mutant alleles.  The reaction compositions consisted of 5.0 
nM WT template to 0.05, 0.5 and 5.0 nM of the mutant templates to construct 1:1, 1:10 
and 1:100 excesses of mutant-to-WT samples, respectively.  Separations used the 
same conditions as those given in Figure 4.4.   
 
4.4 Conclusions 
We have demonstrated the successful genotyping of four clinically relevant K-ras 
markers important for diagnosing CRCs by a hybrid LDR-FSCE method that generated 
fluorescently labeled LDR-dt products.  The versatility of the LDR-FSCE method allows 
for multiplexed, highly specific mutation profiling of samples containing up to 100-fold 
[111] 
 
excess of WT sequences on a plastic microchip.  The LDR-dt products were separated 
in 11 min on a commercial CAE system and ~85 seconds on a dynamically coated 
separation channel of a PMMA microchip that was replicated via hot-embossing.  LDR-
FSCE is a highly flexible method; drag-tags are ideal for genotyping applications that 
require high-resolution separations of short oligonucleotides.  Moreover, the absence of 
a highly viscous sieving matrix also simplified the operation of the chip-based 
electrophoresis by eliminating the need for gel filling prior to the electrophoretic 
analysis.  Thus, narrower channel dimensions to improve electrophoretic efficiency or 
increasing the channel number within the device to improve throughput could be 
realized without the constraints of high pressure that can result in device failure due to 
disassembly.   
Future work will include the integration of genomic sample pre-processing, 
including DNA extraction and thermal cycling, onto a polymeric wafer to produce 
autonomous systems appropriate for genotyping applications that do not require sieving 
matrices or gel-filling apparati [44].  In additions, improvements in FSCE performance to 
handle highly multiplexed assays can be realized with the utilization of polyamide drag-
tags of larger sizes.  The degree of multiplexing will also be increased to probe the 
entire panel of 19 K-ras mutations associated with the development of CRC as well as 
other well characterized disease states by the incorporation of a larger array of drag-
tags.  
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Chapter 5:  Evaluating Low Frequency p53 Mutations Using an Endo V Mutation 
Scanning Assay and Microchip Electrophoresis 
 
5.1 Introduction 
An accumulation of genetic mutations stemming either from inherited or somatic 
alterations are ultimately responsible for spawning most cancer-related diseases.  
Overall, approximately 90% of all cancers are attributed to somatic mutations, ~20% are 
the result of germline mutations and ~10% involve both types [1].  The Human Genome 
Project (HGP) has resulted in a rapid progression of the identification and 
characterization of many deleterious genetic alterations that can be associated with a 
variety of diseases, including cancer [2].  This information has provided insights into the 
structure and function of oncogenes and tumor suppressor (TS) genes both of which 
play a pivotal role in tumorigenesis.  Oncogenes produce growth and signal 
transduction factors that promote cell growth and proliferation [3]. Meanwhile, active TS 
genes, which are often found deactivated in my cancer-related diseases, regulate cell 
growth and initiate apoptosis in cells that cannot be repaired, but under certain 
circumstances, deactivated TS genes can be reactivated [4, 5].  
The multiple and overlapping frequencies of many mutations associated with 
particular cancers must be accurately mapped and evaluated in clinical settings to 
realize diagnostic and prognostic metrics using these biomarkers.  For example, K-ras 
mutations in codons 12 and 13 occur in 80 – 90% of pancreatic cancer and 35 –50% of 
colorectal cancers [6-8]; single nucleotide polymorphisms in BRCA1 and BRCA2 
present at low frequencies (1 – 5%) are linked to significantly higher risks of developing 
breast, ovarian or prostate cancers for certain ethnic groups [9].  A locus in 
chromosome region 15q25 encompassing several genes - including three that encode 
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nicotinic acetylcholine receptor subunits (CHRNA3, CHRNA4, and CHRNA5) – have 
been found to account for 14% of 1,989 lung cancer cases, which were assessed in a 
recent study [10].  The location of these mutations are well known and thus, can be 
analyzed using mutation detection assays, such as allele specific ligation [11], allele 
specific PCR [12] or allele-specific hybridization [13]. 
The presence or likelihood of developing cancer-related diseases have also been 
related to the frequency or occurrences of sporadic p53 (TS gene) mutations [14].  The 
challenge of evaluating these mutations is that they are often inundated by excess wild-
type DNA in clinical samples at early stages of development and also, their locus is not 
defined [15].  For instance, frequencies of sporadic p53 mutations in exons 5 – 9 can be 
as low as one mutant per 1,000 wild-type (WT) sequences [16] and over 22,000 p53 
mutations in different human cancers have been recorded and compiled in an 
accessible database [17]. 
Several methods have been developed to detect sporadic mutations including 
hybridization analysis using high-density oligonucleotide arrays [18], denaturing high-
performance liquid chromatography (DHPLC) [19, 20], single strand conformational 
polymorphism (SSCP) [21], denaturing gradient gel electrophoresis (DGGE) [22], 
heteroduplex analysis (HA) [23] and dideoxy-sequencing [24].  Unfortunately, none of 
these methods have the combined ability to provide low level detection when the 
mutated DNA is in a large excess of WT DNA and also, pinpoint the exact location of 
the sporadic mutations.  Although dideoxy-sequencing can detect any single nucleotide 
polymorphism and determine its location, the procedure is often time-consuming and 
lacks the necessary sensitivity to detect low abundant mutant DNA in large excesses of 
WT DNA.   
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An approach for determining the approximate location of sporadic polymorphisms 
even in the presence of large excesses of WT DNA is the use of enzymes, such as T4 
Endonuclease VII to cleave mutational sites within double-stranded DNA [25, 26].  
However, these methods generally suffer from miscleavages leading to false signals, 
which limit their usefulness.   
 Recently, a one-step mutation scanning assay has been reported (see Figure 
5.1), which employs Thermotoga maritima Endonuclease V (Endo V). Endo V is a 
mutation nicking enzyme that clips a duplexed DNA molecule containing mismatched 
base pairs (i.e., heteroduplexes). Unfortunately, Endo V can nick dsDNA at matched 
sites as well that can be subsequently repaired using AK16D Taq ligase, which reduces 
background signals from incorrect DNA cleavage events [27].  This particular Endo V 
primarily recognizes and cleaves heteroduplexed DNA one base from the 3’-end with 
respect to the mismatch. Combined with a ligase detection reaction (LDR) [28, 29] using 
the Thermus species AK16D thermostable ligase, which displays up to a 5-fold better 
discriminatory power compared to other ligases [30-32], this Endo V/LDR strategy has 
been shown to provide sensitivity of up to 1:50 (Mutant to WT DNA) for the scanning of 
sporadic p53 mutations.  Furthermore, this strategy employs universal PCR 
amplification steps making it amenable to multiplexing [27]. The terminal step required 
in this Endo V/LDR assay is a high-resolution electrophoresis step that sizes the DNAs 
in their single-stranded form to determine the origin of the nicks induced by Endo V.  
The technological trend towards miniaturizing electrophoretic platforms for DNA 
separations initiated during the HGP has impacted genetic analyses for clinical 
diagnostics/prognostics as well and has led to devices that provide high resolution 
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separations that are potentially faster, possess simple operational characteristics and 
have lower cost compared to conventional capillary electrophoresis. 
 
 
Figure 5.1.  Diagram illustrating the outcome of a successful Endo V/LDR treatment of 
dye-labeled, heteroduplexed substrates. PCR amplicons of known wild-type cell lines 
and mutagenic cell lines having high levels of sporadic mutations are cross-paired and 
heteroduplexed to form Endo V targets.  Endo V preferentially nicks DNA one base 3’ to 
the mismatch, but also generates nonspecific nicks with minor activity.  DNA ligase is 
used either subsequently or concurrently with Endo V to reseal these background nicks. 
 
 
In addition, these microchip electrophoresis devices can be integrated to upstream 
sample pre-processing steps to create fully automated systems for mutation analysis.  
Efforts have prompted the engineering of various high-throughput and highly integrated 
electrophoretic devices in glass and, most recently, a host of polymeric substrates, 
which are relatively inexpensive and conducive to a variety of high production-mode 
fabrication techniques making them appropriate for clinical application, which require 
one-time use devices to prevent false-positive signals arising from sample carryover 
[33-36].   
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Recently, mutation detection and scanning assays, which depend on an 
electrophoresis step for reading the results of the molecular assay, have been 
demonstrated.  For example, mutation scanning assays that have been transitioned to 
microchip platforms include SSCP and HA [37-39].  Many of these reports emphasized 
numerous operational parameters, such as electrophoresis temperature and polymer 
matrix/denaturing additive concentrations that must be optimized to provide highly 
sensitive detection for mutational analyses possessing adequate resolution for detecting 
the target mutations [40-42].   
 Here we present adaptation of the highly sensitive Endo V/LDR mutation 
scanning assay onto a poly(methyl methacrylate), PMMA, microchip for separation of 
the generated products using high-resolution electrophoresis for sorting the single-
stranded products generated.  Comparisons of the separation performance for 
identifying sporadic p53 mutations via Endo V/LDR performed using conventional 
capillary gel electrophoresis and with polymer-based microchip gel electrophoresis will 
be evaluated.  The goal of this work is to assess the ability of this mutation scanning 
assay to be transitioned to a microfluidic platform and its potential for detecting low-
abundant sporadic mutations using microchip-based scanning methods.   
5.2 Methods and Materials  
5.2.1 Protocol for DNA Template Preparation   
Genomic DNA was extracted from HT-29 and LoVo cell lines having known K-ras 
oncogenic expressions associated with the onset of colorectal cancer (ATCC, 
Manassas, VA) using a Qaigen DNeasy kit (Valencia, CA);  the LoVo cell line contains 
wild-type p53 gene mutations and HT-29 cell lines contain exon 8 R273H (G→A) 
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mutations. All of these epithelial cell lines were obtained from colorectal 
adenocarcinomas. 
5.2.2 Protocol for Universal PCR Amplification 
All primers used for Endo V/LDR were purchased from IDT (Coralville, IA) or 
LiCOR Biotechnologies (Lincoln, NE).  Universal PCR reactions for amplification of p53 
exon 8 gene fragments followed by universal primer amplification (50 mL) containing 20 
mM Tricine, pH 8.7, 16 mM (NH4)2SO4, 2.5 mM MgCl2, 0.2 mM of dNTPs, 0.2 mM of 
each universal primer, 0.02 mM of each gene-specific primer, 5 U of AmpliTaq Gold 
DNA polymerase and 150 ng of genomic DNA (see Table 1 for primer sets).  
 
Table 5.1. PCR primers used for universal gene amplifications 
 
 
The first thermocycling conditions in the bi-level amplification for the gene-
specific template amplification were: 95ºC for 10 min to activate AmpliTaq Gold 
polymerase, followed by 20 cycles of 94ºC for 30 s, 65ºC for 1 min, 72ºC for 1 min.  
Secondly, the universal amplification cycling conditions were: 30 cycles of 94ºC for 30 s, 
55ºC for 1 min, 72ºC for 1 min, followed by a final extension step at 72ºC for 7 min.  In 
the universal PCR reaction, the universal primer pair consisted of a forward dye1-
labeled primer and a reverse dye2-labeled primer for the standard 
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denaturation/renaturation procedure. The dye1 and dye2 designation represent different 
dye sets matching capillary array electrophoresis (CAE) and microchip detection 
systems; for CAE analyses, dye1 and dye2 were FAM (ex./em.= 492, 517 nm) and HEX 
(ex./em.= 538, 559 mn), while HEX and IRD-800 (ex./em.= 782, 812 nm) were used for 
the microchip system. In this procedure, PCR amplification used one labeled universal 
primer and one unlabeled universal primer (see Figure 5.2). 
5.2.3 Preparation of Heteroduplexed DNA Substrates 
For the denaturation/renaturation procedure required for heteroduplex formation 
for the Endo V phases of the assay, approximately equal ratios of dye1/dye2-labeled 
wild-type PCR amplicons were mixed with dye1/dye2-labeled mutant PCR amplicons in 
a 12 mL final volume (1500 ng total DNA).  The wild-type control consisted of 
dye1/dye2-labeled wild-type DNA PCR products alone in a 12 mL final volume (1500 ng 
total DNA). The residual Taq DNA polymerase was inactivated by adding 1 mL of 
proteinase K (20 mg/mL) to each mixture and incubating at 65ºC for 30 min, followed by 
a 10 min incubation at 80ºC to deactivate the proteinase K.  PCR mixtures were then 
heated at 95ºC for 2 min, and gradually cooled to room temperature with a 0.2ºC 
decrease in temperature every 15 s to 45ºC,  and finally with a 10 min incubation at 
25ºC to generate heteroduplexes as shown in Figure 5.2.  
5.2.4 Endo V/ LDR Assay 
  
A 6.5-µl volume of each denatured/renatured PCR mixture was incubated at 
65˚C for 2 h in a 20 µl volume reaction containing a reaction cocktail (80 mM Tricine pH 
8.0, 5 mM MgCl2, 5 mM dithiothreitol (DTT), 5% dimethyl sulfoxide (DMSO), 1.5 M 
betain, 2% glycerol, with 500 nM Endo V, 6 nM Taq ligase (LDR repair enzyme) and 5 
mM nicotinamide adenine dinucleotide (NAD), pH 8.5). Then, reactions were terminated 
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with the addition of EDTA to a 10 mM final concentration to inhibit any further Endo V 
cleavage activity.  Using the given buffer conditions, both Endo V cleavage and LDR 
DNA repair of miscleavages via thermostable ligation were carried out simultaneously. 
 
 
Figure 5.2.  Schematic illustration of the universal PCR amplification, labeling and 
cross-pairing of wild-type LoVo and mutagenic HT-29 templates and the resulting 
homoduplex (control) and heteroduplex targets. 
 
  
5.2.5 Microchip Fabrication 
Microchips were fabricated using methods previously developed and reported in 
our group [33] .  Briefly, the procedure involved machining a molding die by micro-milling 
raised microstructures onto a brass plate.  These microstructures formed a separation 
channel with dimensions of  70 m (depth) x 30 m (width) that was 9.5 cm long with 
0.5 cm intersecting side channels offset by 500 µm, which provided a defined 105 pL 
volume for sample injection. These microstructures were embossed into PMMA plates 
(MSC, Melville, NY) using an embossing system consisting of a PHI Precision Press 
model number TS-21-H-C (4A)-5 (City of Industry, CA) and a vacuum chamber 
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connected to the press to remove air (pressure, < 0.1 bar).  The microchannel pattern 
was transferred into a PMMA plate at 155°C and 1000 lb for 4 min.  After hot-
embossing, the press was opened and the polymer was cooled to room temperature.  
Reservoirs were added to the microchips by drilling 1.25 mm holes centered at the end 
of each channel.  After an ethanol rinse and sonication in ddH2O for debris removal, the 
final device was assembled by annealing a PMMA cover plate to the open face of the 
device by clamping between glass plates and heating to 107 C in a circulating air oven 
for 20 min.  
5.2.6 Laser-induced Fluorescence (LIF) and High Voltage Control System 
A laser-induced fluorescence (LIF) detection system was constructed in-house 
with an epi-illumination configuration.  A diode 780 nm laser filtered with a band-limiting 
line filter (Thorlabs, Newton, NJ) was directed onto a dichroic mirror, which reflected the 
excitation beam through a 40x microscope objective (Newport, Fountain Valley, CA) into 
the microchannel, which was situated on an X-Y-Z micro-translational stage.  The 
fluorescence emission was filtered through a filter stack and focused onto a single 
photon avalanche diode (model SPCM-AQR-12, Optoelectronics, Vaudreuil, Canada).  
The filter stack consisted of an 825 nm bandpass filter (Oriel, Stratford, CT) and an 800 
nm long-pass filter (Edmund Scientific, Barrington, NJ).  The LIF signals were acquired 
on a personal computer using a 32-bit counter/timer board (Model PCI-6601, National 
Instruments, Austin, TX).  
A custom Lab-View program was used to control applied voltages for the 
microchip electrophoresis.  The unit included three internal high voltage power supplies 
(EMCO, Sutter Creek, CA) capable of receiving inputs of 0 or +5 V from a DAC (digital-
to-analog converter) outputs of a CYDDA 04P board (CyberResearch, New Haven, CT).  
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These power supplies were capable of delivering 0 to +2 kV to sample and waste 
reservoirs (EMCO Model C20, Sutter Creek, CA) and +0.3 to +5 kV to the anode 
reservoir (EMCO Model G50), all of which could be dynamically altered throughout the 
separation.   
5.2.7 Capillary and Microchip Conditions for Endo V/LDR   
Separations of the Endo V/LDR products were performed on an ABI 3730 
(Applied Biosystems) using 36 cm (31 cm effective separation length) capillaries filled 
with POP7 gel (Applied Biosystems), which was used in conjunction with POP7 buffer.  
Samples were diluted 1 to 10 with HiDi formamide and 0.4 L of a Genescan size 
standard (Applied Biosystems), which were denatured at 95ºC for 2 min (to ensure all 
duplexes were converted to single strand form) and electrokinetically loaded into the 
capillaries by applying 277 V/cm for 10 s and electrophoresed  at 416 V/cm.  For the 
microchip analysis, separations were performed at room temperature using 
microchannels filled with a 2.75% w/v sparsely cross-linked polyacrylamide suspended 
in 1x TTE (50 mM Tris, 50 mM TAPS, 2 mM EDTA) buffer containing 7 M urea following 
a rinse with 0.05% (w/v) methyl hydroxyethyl cellulose, MHEC (Sigma Aldrich, St. Louis, 
Mo) to dynamically coat the PMMA channel walls for electroosmotic flow (EOF) 
suppression [43].  To generate a volume-defined injection plug, 347 V/cm was applied 
for 30 s from the sample reservoir (ground) to the waste reservoir (+ 3.5 kV).  
Electrophoresing of the sample was conducted using 125 V/cm, while adduction 
potentials of 345 and 276 V/cm were applied to sample and waste reservoirs, 





5.3 Results and Discussion 
5.3.1 Universal PCR Products 
As seen in the Figure 5.2, these pre-processing steps overall yield DNA duplexes 
bearing unique fluorescent labels in order to ascertain whether mutation products 
present were derived from the top or bottom strands. This universal labeling strategy 
was implemented to eliminate the need for obtaining (expensive) fluorescently-labeled 
primers for high throughput scanning over several target loci. In order to verify 
successful universal PCR amplification, all amplicons were separated on a 2% agarose 
gel and compared to a size standard as seen in Figure 5.3.  From this image, a band 
intensity measurement relative to the weighted size standard was determined to 
quantify the total concentrations for each template in order to determine the relative 
yields of the denaturation/renaturation processes.  This was required as high DNA 
concentrations (125 ng/µL) and very small decreases in annealing temperature (- 0.2 
°C/min) are critical the generation of heteroduplexes.  The DNA concentrations of the 
amplicons in lanes 2 – 5 were were ~150 ng/µL compared to the negative control 
samples containing no universal primers for secondary amplification, which were ~8 
ng/µL. 
5.3.2 Capillary Separations of Endo V/LDR Products 
Prior to microchip analyses, separations of the Endo V/LDR products were 
conducted using a commercial ABI 3730 CAE system to ensure the reactions were 
successful and to provide a comparison of the microchip electrophoresis to previous 
results using capillary array electrophoresis [27].  Figure 5.4 shows the presence of p53 
mutations due to the observance of ssDNA bands appearing at 158 and 194 bases 
when referenced against the DNA sizing ladder (see Figure 5.4), which have been 
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confirmed via DNA sequencing [44].  As depicted in Figure 5.4, the panel on the right is 
a simplified band representation of all of the peaks generated from each of the six 
electropherograms, which was produced using customized software.  As a simplified 
representation of the multi-channel output from the CAE system, a band representation 
of the CAE electropherogram is shown in the left panel of Figure 5.4 and it was used to  
   
 
Figure 5.3.  A 2% agarose gel/1x TBE running buffer separation verifying the 
generation of 350 bp universal amplicons of wild-type and mutagenic targets to be 
heteroduplexed.  Separation was conducted with a 10 V/cm field strength and DNA was 
stained with ethidium bromide.   
 
evaluate treated samples for the presence of mutations within the amplicons from either 
the top or bottom strands of the heteroduplexes according to their unique fluorescent 
labels.  The third set of bands (orange) of relatively low intensity in each lane represents 
an internal size standard against which the DNA lengths present were referenced.  The 
Endo V treated samples in lanes 1 – 3 showed elevated levels of sample cleavage 
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resulting in several bands that were <110 bp in size, which were a mixture of primers 
and miscleaved products.  However, lanes 4 – 6, which were treated with both Endo V 
and an LDR, showed a significant reduction in false signal bands generated from Endo 
V cleavage events arising from cleavage at fully matched sites.  Also, no product bands 
were present in the wild-types controls samples as expected (see lanes 1 and 4 in 
Figure 5.4). 
Figure 5.4. Capillary electrophoretic separations of Endo V and Endo V/LDR treated 
DNA samples.  Heteroduplexed mixtures of wild-type and mutant DNA amplicons from 
LoVo and HT-29 cell lines, respectively, were incubated in the optimized reaction 
cocktail conditions, which included a 2 h Endo V reaction at 65˚C. 
 
5.3.3 Microchip Separation of 32 Component Size Standard 
 In order to determine the ability to generate sufficient plate numbers and 
resolution for the Endo V/LDR products required for this mutation scanning assay, 
which range in size from 100 bp to 350 bp, we optimized the microchip separation 
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conditions using a 600 bp sizing ladder composed of 32 single stranded DNAs as a 
reference.  As shown in the electropherogram in Figure 5.5, a PMMA microchip filled 
with a 2.75% (w/v) nanogel [45] suspended in 1x TTE and 7 M urea following a channel 
flush with 0.05% (w/v) MHEC (for EOF suppression) was capable of providing near 
baseline resolution for all 32 components of this 600 bp sizing ladder having 5, 10 and 
20 bp differences in size.  This sparsely cross-linked linear polyacrylamide (LPA) was  
 







32 Component 600 bp Size Standard









Figure 5.5.  PMMA microchip separation of a 32 component Beckman 600 bp size 
standard.  The separation was performed using a 2.75% w/v nanogel constituted in 1x 
TTE, 7 M urea buffer with a separation voltage of 125 V/cm at a detection length of 




reportedly synthesized by incorporating a low percentage (~10-4 mol %) of N, N-
methylene bisacrylamide (Bis) cross-linker in high-molar mass LPA, which generates 
localized cross-linking whereby ~75% of the polymer chains in the nanogel incorporate 
at least one point of cross-linking.and allows  LPA to remain fluid [45].  We found this 
nanogel matrix provided ~18% greater resolution than a 4% LPA matrix prepared with 
the same buffer constituents, which was determined by the differences in the respective 
resolutions between 100/110, 300/320 and 580/600 bp markers of size standard 
separations.  The PMMA microchip separations were conducted at field strength of 125 
V/cm with sample adduction fields of 345 and 276 V/cm and an effective column length 
of 6.0 cm.  The high resolution generated for this size standard separation using the 
PMMA microchip with the nanogel matrix was therefore considered to be a viable 
combination for the sorting of cleaved, miscleaved and uncleaved DNA fragments within 
the Endo V and Endo V/LDR treated samples.  
5.3.4 Microchip Separation of Endo V/LDR Products 
 The described LIF system used in conjunction with the microfluidic chip was 
capable of only single color detection.  Therefore, only one of the two labeled mutations 
(dye1-labeled 194 bp product) was analyzed in this assessment.  Figure 5.6 shows the 
separation results of a negative control, which consisted of 1:5 mutant and wild-type 
p53 exon 8 sequences from HT-29 and LoVo cell lines, respectively. Here, no Endo V 
enzyme was added during the final treatment incubation.  This microchip separation as 
well as the Endo V and Endo V/LDR separations were also performed using a 2.75% 
(w/v) nanogel constituted in 1x TTE, 7 M urea buffer with a separation voltage of 125 
V/cm at a detection length of 6.0 cm.  Upon separation development, the only visible 
components in the sample were residual fluorescently-labeled PCR primers remaining 
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after the PCR amplification and the 350 bp heteroduplexed PCR amplicons, which were 
in the single-strand form via denaturation with formamide prior to performing the 
separation.  This Endo V control microchip and was completed within 6 min comparable 
to the same separation performed on the CAE system (data not shown).  Thus, all other 
peak fragments present in the Endo V treated samples upon microchip sorting were 
attributed to Endo V activity.  
 



















Figure 5.6. PMMA microchip separation of a negative control sample, which was not 
subjected to Endo V treatment. Electrophoretic run conditions were the same as those 





 As seen in Figure 5.7, the microchip separation of an Endo V treated 1:5 
mutB/wtA sample using the same conditions given in Figure 5.5 reveals that several 
fragments of  wtA/mutB heteroduplex, which were not present in the negative control 
PMMA microchip separation.  Upon evaluation of the separations, most of the 
miscleavages resulted in several partially resolved fragments ranging from the excess 
primer peaks used for the universal amplicon generation (~20 bases) to approximately 
110 bases.  Therefore, these peaks represented false signals due to non-specific 
cleavage as measured against the size standard separation, which were similar to those 
observed in the CAE separations (see lanes 4 – 6 of Figure 5.4).  As seen, the resulting 
microchip Endo V separations were in agreement with the elevated presence of 
amplicon fragmentation just prior to the 158 and 194 base mutation products of the 
Endo V separations performed on the CAE system.  Interestingly, the microchip 
efficiencies of the Endo V separations were relatively low (N = 1.42 x 105 plates/m) in 
comparison to that obtained in the microchip separation of the size standard (N = 1.2 x 
106 plates/m), which was determined by measuring a peak in both electropherograms 
located at approximately 300 s. This could possibly be attributed to high levels of 
miscleaved fragments of the same approximate size, which may have co-migrated as 
higher efficiencies of the Endo V sample peaks in the CAE separations (i.e., N ≥ 7.0 x 
106) were measured. The low sample recovery following the desalting sample prior to 
analysis on the microchip could also be a factor.  The peak present at Tm= 304 s was 
determined to be the 194 base mutation product upon comparison to the size standard, 
which has a 200 bp marker at Tm= 298 s.  This microchip separation was completed 
within 6 min compared to the CAE system, in which the analysis time was 
approximately 1 h. 
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Figure 5.7.  PMMA microchip separation of a wtA/mutB Endo V treated heteroduplex. 
Run conditions were the same as given in Figure 5.5. 
 
 The separation of a 1:5 mutB/wtA sample treated with both Endo V and a 
concurrent LDR is shown in Figure 5.8.  As observed in the parallel CAE separations, 
fewer peaks generated via miscleavages from Endo V activity were present after the 
LDR repair treatment, which suppressed several spurious signals in the 100 – 110 bp 
range preceding the expected product location at 194 bp.  The peak profile for this 
microchip analysis was also similar to the CAE separations of Endo V/LDR treated 
samples (see lanes 1 – 3 of Figure 5.4).  Upon comparison to the 600 bp size standard, 
it was determined that the pronounced peak present following LDR resealing having a 
migration time of 290 s was the 194 bp mutation product as it was within close proximity 
(Δtm= 8 s) to the 200 bp marker.  The efficiency for the 194 bp product peak was 2.91 x 
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105 plates/m, which was slightly greater than that of the same product detected in the 
Endo V only treated sample.  Upon the completion of a two-color LIF system, the size 
standard will be internalized in the same separation to further validate the Endo V 
product identities.  The relative differences in overall signal intensities of these 
microchip electropherograms were also attributed in part to low sample recovery 
efficiencies following a desalting procedure. 
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Figure 5.8.  PMMA microchip separation of a wtA/mutB Endo V/LDR treated 
heteroduplex. Upon LDR treatment, the 194 bp p53 mutation product is observed.  Run 
conditions were the same as given in Figure 5.5. 
 
5.4 Conclusions 
 The PMMA microchip separation of sporadic p53 mutations interrogated using a 
novel, dual-enzyme Endo V/LDR assay provided some interesting results when 
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compared to CAE analysis of these sporadic mutations.  The preliminary results 
suggest that Endo V/LDR products could be successfully separated and detected on the 
PMMA microfluidic filled with a sparsely cross-linked replaceable polyacrylamide in 
solution in less than 6 minutes, which was approximately a tenth of the development 
time of the 1 h CAE performance.  Comparing the Endo V negative control, Endo V and 
Endo V/LDR sample separations, characteristics of Endo V cleavage and the 
subsequent clean-up of spurious false signals were observed in microchip separations, 
which were similar to that obtained with CAE separations.  A two-color LIF system is 
currently being devised to allow the full two-color read-out of the existing multiplex 
assay. Also, front-end sample processing including the universal PCR and 
heteroduplexing of target DNAs could be integrated on-chip reduce the ~5 h sample 
preparation time presently required.      
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Chapter 6:  Conclusions and Future Work 
 
6.1 Conclusions  
The ever growing understanding of DNA and its linkage to disease development 
has demanded vast improvements in genotyping technology.  The abundance of DNA 
processing necessary to further this base of knowledge has far out-paced antiquated 
slab gel systems and even the capillary array systems, which greatly aided in the 
completion of the sequencing of the human genome.  Undoubtedly, the current 
miniaturization of electrophoretic platforms represents the future of DNA processing 
technology.  It is expected that the development of polymer microchip separations for 
DNA analyses presented in the preceding chapters will be a significant contribution in 
the advancement of genotyping technology. 
 The evolution of genotyping platforms was alluded to in Chapter 1. The 
fundamentals of DNA structure/composition and processing including DNA replication 
(PCR) and genotyping methods as well as the electrophoresis and fluorescence 
detection of DNA were introduced. 
 The current and noteworthy genotyping accomplishments using microchips as 
electrophoretic platforms were discussed in Chapter 2.  This chapter expanded in depth 
on the growing field of miniaturized separation devices for mutation screening and 
scanning, forensics and sequencing applications.  Highlighted in this chapter were the 
myriad of genetic conditions currently being investigated using microfluidics and trends 
of the increasing utilization of polymer substrates for the development of planar 




architectures and unprecedented levels of integration for front-end sample manipulation 
allowing complete lab-on-a-chip processing of DNA samples were reviewed.      
Polymer microchip sorting of mutation products derived from a novel LDR assay 
was premiered in Chapter 3.  Although widespread utilization of this Taq ligase-based 
genotyping technique was evident in the scientific literature since its inception in 1991, 
no microchip sorting adaptations of LDR products, including polymer and glass 
substrates, had previously been demonstrated.  Recognizing the potential value of this 
genotyping method on a miniaturized electrophoretic platform, a productive 
collaboration with the research group of Francis Barany at Weill Medical College of 
Cornell University was forged leading to the initial polymer microchip separations of 
LDR products.  Evaluating a host of polymer solutions, a 4% LPA solution was found 
favorable in providing high efficiency separations for an individual LDR product from its 
reaction constituents with adequate resolution in the small fragment size range of 
interest in as little as 120 s, nearly 17-times faster than capillary gel formats.  In 
addition, sample processing prior to the electrophoresis was simplified by eliminating 
the need of desalting using ethanol precipitation or other similar techniques.  Later, it 
was demonstrated that two simultaneously generated LDR products of a 1 to 100 low 
abundance mutation ratio could be effectively resolved on the same microchip using a 
sparsely cross-linked, low viscosity solution in approximately 4.5 min.  
Directly stemming from the challenges presented in adapting the separation of 
relatively small LDR products onto a polymer microfluidic, a novel strategy of separating 
LDR primers in free solution was developed as described in Chapter 4.  In collaboration 




for the first time by redesigning LDR primers to allow attachment of molecularly-
engineered set of polyamide drag-tags, which imparted unique frictional forces on DNAs 
having essentially the same size.  Following the development of reaction conditions 
amenable for both drag-tag and LDR constituent fidelities, free solution electrophoresis 
cross injection and separation conditions were developed and optimized to sort LDR-dt 
products on PMMA microchips.  Although the single base size differences of these LDR 
products were miniscule in terms of relative electrophoretic mobility for small DNA 
fragments, baseline resolutions were achieved for four clinically relevant colorectal 
cancer mutations.  Low abundance mutation detection levels of 1 in 100 DNA molecules 
and simultaneous detection of multiple (four) mutations were achieved.  Implementation 
of this free solution separation mechanism, LDR analysis times reached a new low of 
approximately 85 s using a PMMA microfluidic, improving upon the rapid 2 min analysis 
times achieved using the same PMMA microchip filled with a host of polymer solutions. 
With the understanding gained from previous studies evaluating gel matrices for 
DNA separations on polymer microchips, the microchip separation adaptation for 
mutation products of a novel Endo V/LDR mutation scanning technique was initiated as 
presented in Chapter 6.  Combined with LDR resealing of spurious DNA clipping, Endo 
V mutation cleavage provided an effective means of detecting unknown mutations 
occurring sporadically with high frequency within tumor suppressor genes. Given its 
effectiveness, it was found appealing to bolster the processing efficiency of the 
technique as the size of Endo V/LDR products fell within a suitable range (> 100 bp) 
favorable for microchip separations.  Preliminary results indicate that microchip 




treated DNA samples as the latter shows fewer peaks, which could be directly attributed 
to Endo V cleavage and the subsequent resealing of DNA targets.  Upon full 
optimization of the separation parameters in conjunction with the completion of a two-
color LIF system, we expect to dramatically reduce the mutation product separation 
performance by at least a factor of ten as observed in the preliminary data. 
6.2 Future Work 
 As alluded to throughout this dissertation, the next critical step necessary to 
realize the promise of transitioning DNA separations onto a miniaturized planar platform 
is the integration of DNA sample preparatory processes onto the same wafer.  Such 
studies have already begun by coworkers within the Soper Research Group for front-
end LDR thermal cycling using a miniaturized continuous flow device.  To date, only on-
chip microarray or off-line CE-LIF detection strategies have been implemented to 
complement this process.  Up until now, the major bottleneck constraining the post 
reaction electrophoretic sorting of LDR products has been the incompatibility of viscous 
polymer solutions within the continuous flow system.  With the development of LDR-
FSCE in hand, seamless on-chip integrated post reaction separations of LDR-dt 
products should now be implemented with relative ease.  In addition, high throughput 
format separations employing multichannel devices will be pursued in conjunction with 
LDR-FSCE since no viscous polymer solutions, which currently influence the choice of 
channel geometries, will be necessary for separations.  Upon the receipt of a larger set 
of polyamide drag-tags, a multiplexed LDR assessment for the entire panel of 19 known 
K-ras mutations will be conducted. This strategy will be employed for other mutation 




work will continue until µTAS units for the rapid and cost effective clinical testing of DNA 
samples are fully developed. 
 Polymer microchips separations of Endo V/LDR mutation products will continue 
to be investigated.  Upon the completion of a two-color LIF system, which is currently 
being devised, Endo V/LDR products separations on this platform will be amenable to 
two-color read-out as intended with the design of the assay.  Once Endo V/LDR 
separations are optimized on this microfluidic domain, front-end sample processing 
including the universal PCR and heteroduplexing of target DNAs could be integrated on-
chip in a similar continuous flow setup as currently developed for LDR to reduce the ~5 
h sample preparation time presently required.      
[143] 
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